Russia through the hidden eye (continuation)

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194
[/QUOTE]
Institute for Economic Strategies
30.12.2023
INSTITUTE, JOURNAL "ECONOMIC STRATEGIES"

"ECONOMIC STRATEGIES" No. 6/2023: THE DOUBLE BOTTOM OF THE FUTURE


The topic of the final issue of the journal "Economic Strategies" in 2023 was the definition of approaches to shaping the future. In his introductory remarks, the editor-in-chief of the journal, Alexander Ageev, reflects on the ability to manage as the ability to perceive and process information, about knowledge, competence and wisdom.

"Economic policy is based on the usual models. More precisely, on the basis of a seemingly pragmatic arbitrary-intuitive mixture of models," the scientist complains. — What happens if the diagnostics are based on outdated models? At the very least, the picture of the future is inevitably built on the basis of them. And so the 'mainstream' of yesterday is rushing into the future at full speed."

According to the scientist, as we get involved in the formation of the image of the future artificial intelligence, approaches to forecasting, analytics, and management are radically changing: "The future will have to be built in completely new formats, whether someone likes it or not. And mathematicians, physicists, chemists, astronomers, physicians, biologists, geneticists, engineers, philosophers, cultural figures and teachers, primarily kindergartens and schools, will have a special word to say."

The "Geoeconomics" section introduces readers to a study by specialists of the Financial University under the Government of the Russian Federation, dedicated to the role of Russia in the geo-economic duel of the 21st century; substantiates the need to change climate and energy policy (article by S. Glazyev et al. "Climate Change and Energy Transition"); reveals the results of the analysis of the transformation of economic globalization in the context of the transition from the American-centric model of the world economy to the multipolar structure of the world community (publication by Prof. V. Perskaya); explains the reasons for Russia's unique success in mitigating the sanctions shocks of 2022 and the signs of its immersion in long-term sanctions stress from 2023 (a study by scientists from the Institute of Economics of the Russian Academy of Sciences).

The article by A. Ageev and D. Mityaev "Isn't It Time to Go Beyond the Flags?" examines the problem of the ontology of economic policies and substantiates the importance of an intensive search for new theoretical and practical solutions in the context of the crisis of the "mainstream" and the polymorphous structure of the world economy.

In the "Digital Society" section, readers will see the end of the publication by V. Budanov et al., devoted to the problems of cognitive collective convergent engineering; the possibilities of the technology of the information space of data and the improvement of public administration are considered (publication by A. Ageev, O. Ivanova, A. Loshchinin); review of the book by A.A. Frenkel and A.A. Surkov "Combining Forecasts as an Effective Tool for Improving the Accuracy of Forecasting".

Readers will also have to evaluate the proposed measures to overcome the current unfavorable dynamics of the economic situation, comprehend the need to reform the system of strategic planning at the current stage of Russia's development; to identify the interconnection and interdependence of the concepts of "competitiveness of the state" and "economic security"; to consider the possibilities of mitigating strategic risks in the field of demography, scientific engineering and mechanical engineering; to analyze the possibility of creating a sector of a cooperative (moral/ethical) economy in Russia, based on the principles of justice, equal opportunities and conservative ethical standards.



THE DOUBLE BOTTOM OF THE FUTURE

A.I. AGEEV – Director of the Institute for Economic Strategies
more for him:
...
Director General of the International Research Institute of Management Problems (IMNIIPU) [IRIAS]
..
PARTNERS
IRIAS actively cooperates with the Russian Academy of Sciences (RAS), as well as with other academies of sciences of the host countries and their scientific organizations.

The Institute maintains close relations with many world-class organizations of the world’s leading countries.
..


1687893980927.png

http://mniipu.org/wp-content/uploads/2017/12/DARPA.jpg
***
A. I. Ageev,
piano,
"War"
22.06.2023



 

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194
23.01.2024
Registration of media representatives for the Future Technologies Forum is open
...
Participants of the event will discuss genetic technologies as part of the medicine of the future, the development of neurotechnologies in healthcare, regenerative medicine as a way to restore lost health, as well as biotechnologies in personalized healthcare, including active longevity technologies and preventive medicine.
...
[...]The Forum will present unique domestic developments that will be introduced into routine practice in the near future. Our country is ready to lead the way in creating the medicine of the future," said Anton Kobyakov, Adviser to the President of the Russian Federation and Executive Secretary of the Organizing Committee.


09.07.2023
Vladimir Putin sent greetings to the participants, organizers and guests of the Forum of Future Technologies
..
President of the Russian Federation Vladimir Putin has sent greetings to the participants of the Future Technologies Forum, which will be held under the motto "Ahead of Time" on July 9-14, 2023 in Moscow. The appeal is posted on the Kremlin's website.
..
Participants, organizers and guests of the Future Technologies Forum

July 9, 2023, 09:00, Greetings

Dear friends!

I welcome you to the Forum of Future Technologies, held under the motto "Ahead of time". It will become traditional and is intended to serve as an open platform for dialogue between representatives of government, business, scientists, to develop joint steps in those research and technological areas that in the near future will determine global development, the future of humanity. Our task, the most important priority of Russia, is to use the enormous potential of such innovative solutions to grow the economy and improve the quality of people's lives.

The current forum is dedicated to quantum technologies. The scope of their application is exceptionally wide: these are new-generation computers, the development and creation of unique medicines and materials, optimization of power grids and logistics, as well as secure data transmission channels, ultra-sensitive measuring devices, medicine and security.


Today, in the face of unprecedented external challenges, and most importantly, large–scale, high-quality renewal of industry, agriculture, all sectors of the Russian economy, public administration and the social sphere, it is fundamentally important that the advanced developments of our engineers and researchers are implemented as quickly as possible. This is the key to strengthening our technological sovereignty, which means national progress, and the growth of the well-being of our citizens. I hope that the Forum of Future Technologies will give an additional powerful impetus to this work.

I would like to note that foreign colleagues will also take part in the upcoming meetings. I see this as a good opportunity to build mutually beneficial cooperation, to form promising technological partnerships and implement joint breakthrough projects.

I wish you success.

Vladimir Putin"
...

10.07.2023
An expanded program of the Future Technologies Forum has been published

..

"The modern economy is becoming more and more a data-driven economy. In such conditions, computing and data transfer technologies are becoming one of the key technologies of the modern economy. And it is important for Russia to be a leader in new technologies that can be revolutionary in nature. This means that quantum technologies and photonics are the areas that need to be given increased attention," said Maxim Oreshkin, Assistant to the President of the Russian Federation.
..
discussions .."Technological sovereignty and Russia's place in international Science: contradiction or synergy?"
..
The block "What will be the technologies of tomorrow"
..
The sessions "Quantum City of the Future", "Quantum computers and sensors in industry: is the future already here?", "Medicine and the man of the future in the quantum world: fiction or reality?" are devoted to the use of new technologies in various fields, and "Blockchain: scaling, security, prospects", which were included in the thematic block "How technologies are changing the world".

The discussion block "Combining science and creativity" includes sessions: "Ethics of the digital world: old utopias in a new light", "The Image of quantum in human consciousness", "Modern Science: engineering or creativity" with questions about the transformations in human life that further digitalization inevitably brings with it.

The technological sovereignty of the country is the key to economic progress, a strategic resource for creating a competitive economy and the foundation for the well-being of residents. Therefore, the main topic of the Forum this year is the development of one of the most promising technologies of the future.

"It is quantum technologies that can become the basis of a new technological order. Within the framework of the Forum, leading experts will discuss promising areas of implementation and the impact of new technologies on people's lives. One of the main key issues will be new models of international cooperation and the role of Russian science. I am sure that the Forum will serve as a basis for a constructive scientific dialogue "without borders" and the emergence of many business partnerships," said Dmitry Chernyshenko, Deputy Prime Minister of the Russian Federation.

Additional events of the Forum include: VTSIOM session "Image of the future: public opinion on high technologies"..


14.07.2023
Results of the Forum of Future Technologies "Computing and Communication. The Quantum World"

...
"Our fundamental task is to bring the entire economy to a qualitatively new level based on big data," the President of Russia said in his speech at the plenary session of the Forum. Vladimir Putin proposed "to prepare a new national project for the period up to 2030, namely a national project for the formation of a data economy, within a year." "At the same time, we should have not just scientific developments and basic solutions, but the entire technological and production chain," the head of the Russian state stressed. "We are talking, in fact, about the backbone infrastructure for our further development, for the future of our economy as a whole. And it is obvious that dependence in this area means serious threats to national security, weakening, or even loss of the country's sovereignty," he said.
...
And today Russia is already among the world leaders in the length of the quantum backbone network.
...
According to experts, the widespread practical use of quantum computing can begin as early as 2025, and on the horizon of 2030, non-quantum technological leadership will become impossible.
...
The Forum of Future Technologies is held under the auspices of the Decade of Science and Technology, announced in 2022 by decree of the President of the Russian Federation Vladimir Putin. The event was organized by the Roscongress Foundation with the support of the Ministry of Digital Development, Communications and Mass Media of the Russian Federation and the Russian Academy of Sciences.
...
The [Roscongress] Foundation interacts with UN structures and other international organizations."


List of instructions following the meeting with scientists and the plenary session of the Forum for Future Technologies

The Head of State approved a list of instructions following a meeting with scientists and a plenary session of the Future Technologies Forum held on July 13, 2023.

September 3, 2023
...
data collection, including the use of highly sensitive sensors based on quantum sensors;

data transmission and development of new generation communication systems;
...
f) with the participation of leading research universities, within the framework of the Future Technologies Forum in 2024, ensure consideration of the development and use of modern technologies in medicine, including biomedical technologies and neurotechnologies.

Report – until February 1 and August 1, 2024;

---
 
Last edited:

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194
Future Technologies Forum 2024


The key event
for presenting cutting-edge scientific solutions and technologies


The business programme will consist of thematic pillars that focus on the development and use of advanced technologies in medicine, as well as a discussion about the key aspects of introducing biomedical and neuro technologies in various fields, such as healthcare and science.

The speakers will include Russian and foreign scientists, researchers, and developers.

The Forum is being organized by the Roscongress Foundation with the support of the Russian Ministry of Health, Russian Ministry of Science and Higher Education, Federal Medical-Biological Agency, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Russian Academy of Sciences, and Russian Quantum Centre. The co-organizers are: Gazprombank, Rosatom State Corporation, and the Moscow Government. The general partner is Sberbank. The strategic partner is Rosseti, PJSC . The strategic scientific partner is Kurchatov Institute National Research Centre. The partners are: Russian Railways and the Skolkovo Foundation. The business programme partner is R-Pharm.

13–14 FEBRUARY 2024



President of the Russian Federation
Vladimir Putin


The Forum aims to provide an open platform for dialogue between representatives of the government, business and scientists in order to develop joint steps for research and technology in areas that will shape global development and the future of mankind in the near term. Our job, Russia’s top priority, is to use the enormous potential of such innovative solutions to ensure economic growth and improve the quality of people’s lives.


06.02.2024

The business program of the Future Technologies Forum 2024 has been published



Technologies Forum, which includes more than 30 expert discussions on 7 thematic tracks. The forum will be held on February 13–14, 2024 in Moscow at the WTC and will present the latest Russian developments and technologies in the field of biomedicine and neurotechnology - the main trends in medicine of the future.

"We are on the verge of introducing completely new, breakthrough medical technologies. Regenerative and nuclear medicine, genetic, digital and neurotechnologies are actively developing. Most of the projects presented at the Forum are aimed at the development of personalized healthcare and preventive medicine. The task of the future is not only to prevent diseases, but also to restore lost functions, organs and tissues of the body, to ensure the prolongation of a healthy and active human life. This will be the focus of the efforts of both the medical and scientific communities, as well as the state as a whole," said Tatyana Golikova, Deputy Prime Minister of the Russian Federation and Co-Chair of the Forum's Organizing Committee.

"The scientific achievements of our country are a reason to be proud, in many respects it is the discoveries of our scientists that set the direction for the scientific community around the world for the coming years. It is gratifying that most of these developments have a practical focus, and in the near future the technologies of the future will be actively used in the country for the benefit of citizens," said Mikhail Murashko, Minister of Health of the Russian Federation.

Expert discussions within the framework of the 'Neurotechnologies in Healthcare' track will reveal the face of neurotechnologies of the future. Technological progress has led to the creation of a number of technological directions in this area, increasing the efficiency of diagnosis, treatment and rehabilitation of patients with neurological, including neurodegenerative diseases.


Regenerative medicine makes it possible to use the capabilities of the body itself to restore its lost functions due to injuries and diseases, actively using cellular products and tissue engineering technologies, developing new materials for implantable products with biological activity, and matrices for replacing and restoring various tissues. Together with reconstructive technologies, the achievements of regenerative medicine are especially widely used in traumatology and orthopedics. The sessions 'Regenerative Medicine and Cell Technologies: A Look into the Future', 'Promising Technologies in Traumatology and Orthopedics', and 'Creation of Artificial Organs and Biological Systems: Technologies of the Future' are devoted to these issues.

A separate block of the business programme of the Future Technologies Forum covers issues of technological sovereignty in the field of biosecurity, where Russia is one of the world leaders and assists other states in this area.

The 'Ecosystem of Future Technologies' track includes the sessions 'The Science of Popularity in Science: How to Attract and Promote?', 'Why Science Is Far from Business, and Scientists Trust Only the State?', and 'Interdisciplinarity of Future Technologies: Synergetic Effects'.

The use of artificial intelligence in healthcare, the development of digital medicine, and the transition to value-based healthcare will be considered as part of expert discussions in the 'Digitalization and Artificial Intelligence Technologies' track.

The 'Biotechnologies in Personalized Healthcare, Including Active Ageing and Preventive Medicine' track will present a wide range of future technologies. Sessions on active longevity, innovative developments in cardiology and cardiovascular surgery will be planned, and the latest technologies in the diagnosis and treatment of cancer and autoimmune diseases will be highlighted. A meeting of the BRICS Working Group on Nuclear Medicine will also be held.


"Within the framework of the Forum, advanced scientific achievements in the field of medicine will be presented, which open up unique opportunities for the diagnosis, treatment and prevention of diseases. The technologies of the future are becoming the technologies of the present before our eyes, what was only a bold idea yesterday has been implemented today and is ready for implementation. Programs to support the development of science are being implemented at the state level, and today we can proudly present the results of this work," said Anton Kobyakov, Adviser to the President of the Russian Federation and Executive Secretary of the Organizing Committee of the Forum.

The business program of FBT-2024 included sessions dedicated to genetic and genomic technologies.
The current state of medical genetic diagnosis and gene therapy will be considered, as well as the current capabilities of genome sequencing technologies in the diagnosis of hereditary diseases immediately after birth and the future capabilities of this direction in the creation of individual gene therapy drugs for patients with hereditary diseases and in maintaining the genetic health of future generations will be presented. Along with this, it will be shown how modern genetic technologies make it possible to create the world's first innovative drugs to combat autoimmune diseases.


The Forum is organized by the Roscongress Foundation with the support of the Ministry of Health of the Russian Federation, the Ministry of Science and Higher Education of the Russian Federation, the Federal Medical and Biological Agency, the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, the Russian Academy of Sciences, and the Russian Quantum Center. Co-organizers: Gazprombank, Rosatom State Corporation, Moscow Government. The general partner is Sberbank. The strategic partner is the Rosseti Group. The strategic scientific partner is the National Research Center "Kurchatov Institute". Partners: Russian Railways, Skolkovo Foundation. The partner of the business program is R-Pharm.

Programme

13.02.2024

World Trade Center Moscow, entrance No. 4, 1st floor, conference hall 1. ROSATOM
10:00–11:30
What Do the Technologies of the Future Need to Become the Technologies of the Present?


Achievements in fundamental sciences have provided a powerful push to the development of applied scientific research, such as in advanced biomedical and genetic technologies and molecular biology. The development of high-tech fields in science is critically important for achieving competitiveness and independence in Russia, especially in such important life support areas in society as medicine. Despite the wide range of existing support measures in scientific and technological fields, the selection of priority areas for research in this area dictates the need to develop qualitatively new approaches for the expert assessment of projects and, consequently, creates new demands on the content and quality of scientific and technological policy planning. The state is then responsible for setting scientific and technological development priorities, which requires careful justification of decisions for supporting and financing those science-intensive areas and projects that will provide Russia’s economy and social sector with the latest domestically-developed technological advancements for the foreseeable future. How can miscalculations during the expert assessment phase of projects in their early stages of development be avoided? What areas of research are most in demand today in the field of medicine?

Session topics :
An Ecosystem for Future Technologies

Moderator:
Andrey Fursenko — Aide to the President of the Russian Federation
Panellists:
Vladislav Baranov — Chairman of the Board of Directors, "My Medical Center" Group of Companies
Oleg Gusev — Leading Researcher, Kazan Volga Region Federal University
Dmitry Zauers — Deputy Chairman of the Management Board, Gazprombank
Irina Panarina — General Manager, AstraZeneca Russia and Eurasia
Victor Kharitonin — Executive Director, Pharmstandart JSC

Front row participant:
Olga Dontsova — Academician, Head of the Section of Physical and Chemical Biology, Department of Biological Sciences, Russian Academy of Sciences; Head of the Department of Chemistry of Natural Compounds, Lomonosov Moscow State University; Professor, Center for Molecular and Cell Biology, Skolkovo Institute of Science and Technology (Skoltech)


World Trade Center Moscow, entrance No. 4, 1st floor, conference hall No. 2. Gazprombank
10:00–11:30
Technologies Helping in the Fight against Neurodegenerative Diseases


Just as life expectancies continue to grow in developed countries, so does the proliferation of age-specific diseases, including neurodegenerative ones, such as Alzheimer’s, Parkinson’s, and motor neurons, among others. That said, contemporary life in cities can be fast-paced and accompanied with high stress levels, which leads to a phenomenon when neurodegenerative pathologies begin to affect ever younger populations. At present, scientists from around the world are trying to understand how these diseases emerge and progress in order to develop a way to prevent them. However, even now some have been successful at creating therapies that can hinder the progression of such diseases, and can even eliminate certain prominent symptoms. Individual therapies allow patients to choose an optimal algorithm for treatment, including pharmacological methods based on genomic analysis, neuro-surgical, and innovative neuro-rehabilitative technologies. What advanced technologies for the diagnosis and treatment of neurodegenerative diseases exist? What is the quickest and most economical method for determining whether there is a heredity risk for developing Alzheimer’s? What is the current status of and what does the future hold for treating neurodegenerative diseases? What personalized programmes for rehabilitating patients with neurodegenerative diseases have proved to be most effective and successful?

Session topics :
Neurotechnologies in Healthcare

Moderator:
Evelina Zakamskaya — Chief Editor, Doctor TV Channel

Panellists:
Sergey Bachurin — Scientific Director, Institute of Physiologically Active Substances of the Russian Academy of Sciences
Anna Bogolepova — Head of the Department of Cognitive Disorders, Federal Centre of Brain Research and Neurotechnologies of the Federal Medical-Biological Agency of the Russian Federation; Professor, Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University of the Russian Ministry of Health
Sergey Illarioshkin — Deputy Director for Research, Director of the Brain Institute, The Research Center of Neurology
Denis Kuleshov — Innovator and Chief Executive Officer, Sensor-Tech
Vladimir Mitkevich — Deputy Director, V.A. Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences
Boris Polyaev — Head of the Department of Medical Rehabilitation of Patients with Disorders of the Central Nervous System No. 2; Federal Center for Brain and Neurotechnology of the Federal Medical-Biological Agency of the Russian Federation
Nikolay Shamalov — Director of the Institute of Cerebrovascular Pathology and Stroke, Federal Center for Brain and Neurotechnology of the Federal Medical-Biological Agency of the Russian Federation; Сhief Supernumerary Specialist Neurologist of the Ministry of Health of the Russian Federation

Front row participant:
Evgeny Nikolaev — Professor, Skoltech Center for Molecular and Cellular Biology


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 3
10:00–11:30

Genetic and Genomic Technologies: New Opportunities in Diagnostics and Personalization


The creation of gene-therapeutic drugs, something unheard in the not-so-distant past, capable of effectively treating patients with defective genes is a 21st century breakthrough in biological medicine. However, on the path leading to both the development and complete adaptation of gene therapy a number of fundamental challenges must be overcome. The incredible variety of ailments alone makes applying a standard protocol for developing, registering, and commercializing new gene-therapeutic treatments nearly impossible, and instead dictates that new strategic approaches for solving this problem be developed. What is the current state of medicinal genetic diagnosis? Where exactly is the advantage of creating and using biobanks? What are the end results of the first year of neonatal screening and non-invasive prenatal DNA screening as part of clinical practices?

Session topics :
Genetic Technologies: Part of the Medicine of the Future


Moderator:
Maria Vorontsova — Member of the Presidium, Russian Association for the Promotion of Science


Panellists:
Oksana Drapkina — Director, National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
Evgeny Imyanitov — Head of the Scientific Department of Biology of Tumor Growth, N.N. Petrov National Medical Research Center of Oncology
Georgy Kostyuk — Chief Physician, N.А. Alekseev Psychiatric Clinical Hospital No. 1 of the Moscow City Health Department; Chief Psychiatrist of the Moscow City Health Department
Dmitry Kudlay — Vice President for the Introduction of New Medical Technologies, Generium
Sergey Kutsev — Director, Academician N.P. Bochkov Medical Genetic Research Center; Chief Freelance Specialist in Medical Genetics of the Ministry of Health of Russia
Maksim Patrushev — Acting Head of the NBICS Nature-like Technologies Complex, National Research Centre ‘Kurchatov Institute’
Olesya Sagaidak — Deputy Medical Director, EVOGEN; Researcher, Federal State Budgetary Institution "National Medical Research Center of Cardiology" of the Ministry of Health of Russia
Konstantin Severinov — General Director, Biotek Campus
Dmitry Trofimov — Director, Institute of Reproductive Genetics, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation



World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 4
10:00–11:30

Regenerative Medicine and Cell Technologies: Looking into the Future

Regenerative medicine is concerned with the renewal and regeneration of the musculoskeletal system and cartilage and how to reverse the effects of injury and disease. Doctors apply advanced cell technologies and tissue-engineered drugs in therapy. Bioengineers develop materials with new properties to produce implants applied in traumatology and orthopaedics. Regenerative medicine could potentially extend human life, replacing worn-out organs and tissue with biotechnical analogues created through 3D bioprinting. The technology already exists to store human cells in a functional state for many years to reactivate when needed. Doing so would change the face of medicine. In the future, it will be possible to grow tissue to replace worn-out cartilage, teeth, skin, blood, and then organs, and then even fragments of brain tissue without having to worry about the body’s rejecting them. Will we ever learn how to kickstart the process of regeneration in our bodies? What is the immediate outlook for the development of regenerative medicine and cell technologies? What is component is most important to the development of regenerative medicine? How safe are cell technologies? How effective are regenerative medicine and cell technologies and what is keeping us from introducing them into clinical practice today?

Session topics :
Regenerative Medicine: A Way to Restore Health

Moderator:
Anastasia Efimenko — Head of the Laboratory of Tissue Repair and Regeneration, Institute of Regenerative Medicine, Medical Scientific and Educational Center, Lomonosov Moscow State University

Panellists:
Ekaterina Vorotelak — Head of the Laboratory of Cell Biology, N.K. Koltsov Institute of Developmental Biology of the Russian Academy of Sciences
Ilya Eremin — Deputy Director for Research, Academician B.V. Petrovsky Russian Scientific Center for Surgery
Marya Lagarkova — General Director, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency
Alexey Lundup — Director of the Scientific and Educational Resource Center for Cellular Technologies, Patrice Lumumba Peoples' Friendship University of Russia
Alexey Martynov — President, Association of Biomedical Cellular Products Manufacturers
Olga Stepanova — Head of the Laboratory of Cell Biology and Regenerative Medicine, V. Serbsky National Medical Research Centre for Psychiatry and Narcology of the Ministry of Health of the Russian Federation



World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 5
10:00–11:30
Promising Technologies for Use in Traumatology and Orthopaedics


Traumatology and orthopaedics are rapidly advancing areas of clinical medicine. According to data from a recent study by the Global Burden of Disease (GBD), some 1.7 billion people worldwide suffer from musculoskeletal system diseases, which have been the leading cause of disabilities. Over the past 30 years, their prevalence has increased by 62%, and the number of years when people must live with such a disability has increased by 59%. According to this study, Russia is in a group of countries with the highest prevalence of degenerative spinal diseases and osteoarthritis of large joints. Therefore, the introduction of high-tech treatment methods into orthopaedics focusing on sustainable restoration of the functions of the musculoskeletal system is an important social task. For example, surgical treatment of hip fractures in older people (using endo-prosthetics or osteosynthesis) contributes to a significant increase in life expectancy, a return to the patient’s previous level of activity, and results in the reduction of cases of disability. Today, high-tech methods are used in almost all areas of orthopaedics and traumatology, which in turn help in the development of new directions, while reducing both surgery times and the frequency of human error. What advanced reconstructive surgical technologies help increase life expectancies? What advanced technologies for exo-prosthetics of the upper and lower extremities are used most successfully in clinical practice today? What are the latest advances in the surgical treatment of paediatric patients? What will promote the use of additive, navigation, and robotic technologies in traumatology and orthopaedics?

Session topics :
Regenerative Medicine: A Way to Restore Health

Moderator:
Evgeniy Goncharov — Head of the Department of Traumatology and Orthopedics, Academician B.V. Petrovsky Russian Scientific Centre of Surgery

Panellists:
Sergey Vissarionov — Director, G.I. Turner National Medical Research Center for Children's Orthopedics and Trauma of the Ministry of Health of the Russian Federation
Vadim Dubrov — Head of the Department of Traumatology, Orthopedics and Disaster Medicine, Faculty of Fundamental Medicine, Lomonosov Moscow State University
Nikolay Konovalov — Deputy Director for Research, N.N. Burdenko National Medical Research Center of Neurosurgery of the Ministry of Health of the Russian Federation
Anton Nazarenko — Director, N.N. Priorov National Medical Research Center for Traumatology and Orthopedics of the Ministry of Health of Russian Federation; Chief Freelance Specialist Traumatologist-Orthopedist of the Ministry of Health of the Russian Federation
Rashid Tikhilov — Director, R.R. Vreden Russian Scientific Research Institute of Traumatology and Orthopedics of the Ministry of Health of the Russian Federation

Front row participants:
Alexander Burtsev — Director, Academician G.A. Ilizarov National Medical Research Center for Traumatology and Orthopedics of the Ministry of Health of the Russian Federation
Dmitriy Dzukaev — Head, Moscow City Spinal Neurosurgical Center, L.A. Vorokhobov State Budgetary Health Care Institution of Moscow City Clinical Hospital No. 67 of the Moscow Healthcare Department
Sergey Salikhov — First Vice-Rector, MISIS University of Science and Technology



World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 6
10:00–11:30

Triad of Future Biosecurity:
Genomic Surveillance, Big Data and Mobile Technologies


Russia is one of the leaders in ensuring biological safety and, as such, provides assistance to other states in this area. A triad of technologies is successfully used to timely forecast and promptly respond to biological safety threats and provides an analysis of the sanitary and epidemiological situation in the country: genomic surveillance, mobile technologies and big data analytics (including AI analytics), and big data, super-integration technologies. Already today, an entire infrastructure has been created, including mobile laboratory complexes, which allow, in nearly real time, to identify new pathogens and changes in the virulence of known strains of bacteria circulating in Russia and neighbouring countries. Enhancing technologies that make it possible to quickly identify new pathogens is a strategically important mission for Russia and will allow us to analyse the situation so authorities can react quickly and proactively. Which technologies for genomic surveillance and big data analysis for biosafety are available today and are being implemented both in Russia and around the world? What will the mobile laboratories of the future be like and what innovations will influence their development? What developments are most effective for promptly responding to threats and increasing the level of biosafety in Russia?

Session topics :
Technological Sovereignty in Biological Safety


Moderator:
Anna Popova — Head of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing – Chief State Sanitary Physician of the Russian Federation

Panellists:
Sergey Borisevich — Head, 48 Central Scientific Research Institute of the Ministry of Defense of the Russian Federation
Vadim Govorun — Director, Research Institute of System Biology and Medicine (RISBM)
Elena Ilyina — Chief Researcher, Research Institute for Systems Biology and Medicine (RISBM)

Josefina Campos — Senior Technical Advisor for the International Pathogen Surveillance Network (IPSN), World Health Organisation Hub for Pandemic and Epidemic Intelligence
Vladimir Kutyrev — Director, Russian Anti-Plague Scientific Research Institute "Microbe"
Alexander Lukashev — Director, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, I.M. Sechenov First Moscow State Medical University
Areg Totolian — Director, Pasteur Saint-Petersburg Scientific Research Institute of Epidemiology and Microbiology
Jelena Jankovic — Assistant of Minister, Ministry of Health of the Republic of Serbia

Front row participant:
Igor Borisevich — Deputy Head, Federal Medical-Biological Agency of the Russian Federation


World Trade Center Moscow, entrance No. 4, 1st floor, conference hall 1. ROSATOM
12:00–13:30

Meeting of the Working Group on the Legal Regulation of Genetic Technologies, Including Genome Editing, and Bioethics Preventing Hereditary Diseases and Promoting Reproductive and Genetic Well-Being

As medical practice adopts more genetic technologies, it becomes easier and more affordable for expecting parents to prevent hereditary disease in their future child. Preconception screening can identify major recessive genetic disorders in expectant parents, determine the risk of transmitting the mutations to the child, and suggest interventions, technologies, and approaches capable of increasing the child’s chances at good health. The many ethical issues inherent to such tests and the genetic nature of mutations in autosomal recessive diseases continue to pose challenges to specialists attempting to interpret the results of the screening, with similar challenges facing the pharmaceutical industry as it works to develop high-tech drugs for the treatment of rare and orphan diseases. This session seeks to promote dialogue in the expert community on the relationship between expanded preconception and prenatal screening and the potential for reducing the frequency of congenital disorders in the country.

Session topics :
Genetic Technologies: Part of the Medicine of the Future

Moderator:
Maria Vorontsova — Member of the Presidium, Russian Association for the Promotion of Science


Panellists:
Olga Gremyakova — Founder, Gordey Foundation
Igor Kogan — Director, D.O. Otta Scientific Research Institute of Obstetrics, Gynecology and Reproductology
Dmitry Kudlay — Vice President for the Introduction of New Medical Technologies, Generium
Elena Nechaeva — Deputy Chief of the Presidential Directorate for Science and Education Policy
Dmitry Trofimov — Director, Institute of Reproductive Genetics, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation
Valery Falkov — Minister of Science and Higher Education of the Russian Federation
Alexander Khokhlov — Rector, Yaroslavl State Medical University of the Ministry of Health of the Russian Federation



World Trade Center Moscow, entrance No. 4, 1st floor, conference hall No. 2. Gazprombank
12:00–13:30
Healthy Aging: Active Longevity


An aging population is inevitably accompanied by an increase in the prevalence of chronic non-communicable diseases and geriatric syndromes, as well as a boost in the proportion of elderly people in the population with reduced functionality and dependent on outside help. In this regard, the goal of achieving healthy active longevity is becoming particularly urgent. Slowing down aging may be 10 times more effective at prolonging a healthy life than preventing individual age-associated diseases. The paradigm of modern medicine is how to develop and introduce active longevity technologies using our understanding of the aging process. Thus, future technologies utilized to address active longevity will be a synthesis of modern organizational solutions to prevent and diagnose diseases at an early stage, which include the latest approaches toward treating diseases and technologies that make it possible to manage aging by carrying out truly personalized prevention and treatment. Ultimately, the introduction of these technologies in the near future will result in the delaying of the age at which diseases develop and in the extension of the period of healthy life. What technologies for the prevention and treatment of cognitive impairment are successfully being used now and will appear in the near future? What modern technologies are being used today to reduce mortality from cardiovascular diseases in different age groups? What innovative technologies for preventing premature aging are the most promising? What system of measures is most effective for maintaining one’s health and active longevity?

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

Moderator:
Alexey Moskalev — Director of the Research Institute of Aging Biology, N.I. Lobachevsky National Research Nizhny Novgorod State University

Panellists:
David Areshidze — Head of the Laboratory of Cell Pathology, Academician B.V. Petrovsky Russian Scientific Center for Surgery
Oksana Drapkina — Director, National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
Vladimir Zhuikov — Executive Director, Investment Department, Russian Direct Investment Fund
Kamila Zarubina — Vice President, Executive Director of the Cluster of Biological and Medical Technologies, Skolkovo Foundation
Inna Reshetova — Chief Physician, Clinic of Preventive Medicine, Academician B.V. Petrovsky Russian Scientific Center for Surgery
Gennady Suhih — Director, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation
Olga Tkacheva — Director of the Russian Gerontological Research and Clinical Center, Research Institute of Translational Medicine, N.I. Pirogov Russian National Research Medical University; Chief Freelance Specialist Geriatrician of the Ministry of Health of the Russian Federation
Svetlana Shport — General Director, Serbsky National Medical Research Centre for Psychiatry and Narcology of Ministry of Heath of the Russian Federation; Chief freelance psychiatrist of the Ministry of Health of the Russian Federation
Sergey Yudin — Director, Center for Strategic Planning and Management of Medical and Biological Health Risks of the Federal Medical and Biological Agency of Russia


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 3
12:00–13:30
Advanced Technologies in Cardiology and Cardiovascular Surgery


Circulatory system diseases are the leading cause of death worldwide. Healthcare costs for the treatment of acute and chronic diseases of the heart and blood vessels are continually on the rise, while the rate of reduction in mortality has not reached the desired levels, the attainment of which would require innovative approaches toward treatment and prevention. Since 2018, the Russian Federation has been rolling out its Federal Project ‘Combating Cardiovascular Diseases’, which primarily focuses on predicting and assessing genetic risks, personalizing medicine in cardiology, using artificial intelligence, and introducing innovations in treatment and cardiovascular surgery. In this regard, the significance of related sectors and the latest developments, such as training and simulating technologies, is increasing. What are the main challenges and trends in the development of cardiology and cardiovascular surgery today? What best practices is Russia currently rolling out for managing the risks associated with cardiovascular fatalities, including primary and secondary prevention, developing educational initiatives, and organizing rehabilitation? How should the effectiveness of innovations in cardiology and cardiovascular surgery be evaluated in accordance with economic, social, and practical criteria?

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

Moderator:
Simon Matskeplishvili — Deputy Scientific Director, Lomonosov Moscow State University Clinic; Member of the Board, Russian Society of Cardiology

Panellists:
Elena Vasilyeva — Chief Freelance Specialist Cardiologist of the Moscow Department of Health; President, Professor, I.V. Davydovsky City Clinical Hospital of the Department of Health of Moscow
Elena Golukhova — Director, A.N. Bakulev National Medical Research Center for Cardiovascular Surgery of the Ministry of Health of the Russian Federation; Chief Freelance Specialist Arrhythmologist of the Ministry of Health of the Russian Federation
Alexandra Konradi — Deputy General Director for Research, Almazov National Medical Research Centre, Ministry of Health of the Russian Federation
Philip Kopylov — Director of the Institute of Personalized Cardiology, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Sofia Milenkina — Cardiologist, “Cardioatlas” Monograph Author
Natalia Mitkovskaya — Director, State Institution "Republican Scientific and Practical Center "Cardiology" of the Ministry of Health of the Republic of Belarus
Philipp Paleev — Deputy General Director for Scientific and Analytical Work, National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation
Eduard Charchyan — Head of the Department of Reconstructive Cardiovascular Surgery, Academician B.V. Petrovsky Russian Scientific Center for Surgery

Front row participant:
Sergey Abugov — Head of the Department of X-ray surgical methods of diagnosis and treatment, Russian Scientific Center for Surgery named after Academician B.V. Petrovsky


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 4
12:00–13:30
Technologies of the Future for Motherhood and Childhood


The most rapidly-paced progress in clinical medicine can be found in gynaecology, obstetrics, and neonatology. The demographic situation in the Russian Federation predicates that only the most advanced methods for preserving the reproductive function of patients be implemented and that innovative methods to care for premature infants be quickly developed, in addition to utilizing only the latest respiratory and nutritional technologies. Approaches toward diagnosing and treating surgically malformations of the foetus, both scientific and practical, are also constantly being improved. Recent advances in intrauterine diseases and the ability to identify genetic disorders before conception to prevent the passing of diseases to an unborn child have contributed to a dramatic reduction in the incidences of inherited diseases. What advanced technologies and capabilities, including those using artificial intelligence, will be used in the gynaecology, obstetrics, and neonatology of the future? How will the latest techniques for preserving the reproductive function of patients affect motherhood and the demographic situation in Russia? What developments are key to combating intrauterine diseases and critical obstetric conditions, and preserving reproductive potential?

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

Moderator:
Dmitry Morozov — Director, Veltischev Research and Clinical Institute for Pediatrics of the N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation; Chief Freelance Pediatric Surgeon of the Ministry of Health of the Russian Federation

Panellists:
Leila Adamyan — Deputy Director for Research, Academician V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology; Chief Freelance Specialist in Gynecology of the Ministry of Health of the Russian Federation
Dmitry Ivanov — Rector, St. Petersburg State Pediatric Medical University of the Ministry of Health of the Russian Federation; Chief Freelance Specialist Neonatologist of the Ministry of Health of the Russian Federation
Leila Namazova-Baranova — Head, Research Institute of Pediatrics and Child Health Protection, Research and Clinical Center No. 2 of the Academician B.V. Petrovsky Russian Scientific Center for Surgery; Chief Freelance Children's Specialist in Preventive Medicine of the Ministry of Health of the Russian Federation
Elena Petryaykina — Director, Russian Children's Clinical Hospital – Branch of N.I. Pirogov National Medical and Surgical Center of the Ministry of Health of the Russian Federation


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 6
12:00–13:30

Digital Technologies as the Basis for Medical Safety in Manufacturing

Digital technologies are widespread in the economy, social spheres, and throughout industry. The transition to digital services in all industries is inevitable, including those with harmful and dangerous factors that can potentially affect a worker’s health adversely. The development of digital technologies makes it possible to digitize data that can assess industrial production, as well as monitor the impact of individual factors on the human body, an activity in which employers are already engaged in today. In line with this, the latest digital devices appearing on the market every year are capable of assessing the slightest changes in workers’ health, as well as understanding the impact certain factors have on employees’ working environment. These devices are mostly used by medical professionals to monitor the health of workers and quickly identify factors that may prevent workers from engaging in certain types of activities. At the same time, more and more people in the world are themselves monitoring their own health by carrying devices and gadgets on their person, which provide personal information about each person to big data databases for instant processing by artificial intelligence, and then receive back recommendations on how to maintain their health. Therefore, the conditions have already been created for the establishment of a unified digital ecosystem with the wilful participation of employees, employers, and medical organizations. What digital technologies are already helping to preserve the health of workers today? In the immediate future, which areas have the most promise, and which ones are moving at the quickest pace developing digital technologies? How soon can we expect the completion of the transition to digital services in all domestic production?

Session topics :
Digitalization and AI Technologies

In partnership with Russian Railways

Moderator:
Elena Zhidkova — Head of the Central Directorate of Healthcare – a branch of Russian Railways

Panellists:
Igor Buhtiyarov — Director, Izmerov Research Institute of Occupational Health; Head of the Department of Occupational Medicine, Aviation, Space and Diving Medicine, I.M. Sechenov First Moscow State Medical University; Chief Supernumerary Specialist in Occupational Pathology, Ministry of Health of the Russian Federation
Pavel Pugachev — Deputy Minister of Health of the Russian Federation
Andrey Pudov — State Secretary – Deputy Minister of Labor and Social Protection of the Russian Federation
Alexey Fetisov — General Director, T1
Evgeny Charkin — Deputy Managing Director, Russian Railways
Tatyana Yakovleva — First Deputy Head, Federal Medical-Biological Agency of the Russian Federation

Front row participant:
Lyubov Zelenkina — Head of the Department for Health Protection of the Department of Industrial and Environmental Safety, Labor Protection and Civil Protection, Gazprom Neft


World Trade Center Moscow, entrance No. 4, 1st floor, conference hall 1. ROSATOM
14:00–15:30

Meeting of the BRICS Working Group on Nuclear Medicine

New cancer cases and high mortality and disability rates are being reported among able-bodied people worldwide with increasing frequency even as the demand for modern nuclear medicine in national healthcare systems grows. Nuclear medicine is being applied clinically across fields, with radionuclide diagnostics becoming routine in the detection of malignant neoplasms and in cardiology and neurology among others. Modern therapeutic methods employing radioisotopes in medicine (targeted alpha therapy, theranostics) are increasingly common in the treatment of various types of cancer. There is significant potential in BRICS for the development and application of nuclear medicine for the diagnosis and treatment of oncological and non-oncological diseases alike. In July 2023, more than 200 representatives from BRICS members Brazil, Russia, India, China, and South Africa participated in the International BRICS Expert Forum on Nuclear Medicine in Moscow and Obninsk. The result was a consolidation of recommendations and proposals from the professional expert community for the development of nuclear medicine and radiopharmaceuticals in BRICS. The initiative was endorsed during the BRICS Health Ministers’ Meeting held in August 2023, and it was recommended that a working group be established to explore the initiatives and other possible projects. The establishment of the working group was welcomed during the BRICS Summit, and all nations were encouraged to join in the task. The group’s first meeting is scheduled to take place soon and will look to discuss and confirm the structure of the group and plans for 2024 and review its first initiatives in nuclear medicine. Overviews will also be presented on the outlook for nuclear medicine in new BRICS members showing an interest in consolidating efforts and working together.

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

Moderators:
Kirill Komarov — First Deputy General Director, Director of the Development and International Business Unit, State Atomic Energy Corporation ROSATOM
Andrey Stanzhevsky — Deputy Director for Research, Academician A.M. Granova Scientific Center of Radiology and Surgical Technologies of the Ministry of Health of the Russian Federation

Panellists:
Tesfaye Henok Abebe — Head of the Clinical Nuclear Medicine Department, St. Paul's Hospital Millennium Medical College
Abdullah AlQarni — Chairman, Saudi Society of Nuclear Medicine and Molecular Imaging (SSNMMI); Secretary General, Arab Society of Nuclear Medicine (ARSNM); Head of Nuclear Medicine and Hybrid Imaging Division, Prince Sultan Military Medical City
Batool Essa Al-Balooshi — President, Emirates Society of Nuclear Medicine and Molecular Imaging (ESNMMI); Head of Nuclear Medicine, Dubai Health Authority (DHA)
Sergey Glagolev — Deputy Minister of Health of the Russian Federation
Habibollah Dadgar — Head of the Nuclear Medicine and Molecular Imaging Department, RAZAVI Hospital
Yehia Omar — Director of PET/CT and Theranostics Unit, Misr Radiology Center

Front row participants:
Jin Du — Chief Technology Officer, China Isotope and Radiation Corporation (CIRC)
Rafael Lopes — President, Brazilian Society of Nuclear Medicine and Molecular Imaging; Director of the Department of Radionuclide Diagnostics and Therapy, Hospital do Coração
Masha Maharaj — Head of Nuclear Medicine Department, Netcare Umhlanga and Hibiscus Hospitals; Secretary, World Association of Radiopharmaceutical and Molecular Therapy (WARMTH)
Anil Kumar Mishra — Professor, Indian Institute of Technology Roorkee


World Trade Center Moscow, entrance No. 4, 1st floor, conference hall No. 2. Gazprombank
14:00–15:30

Technologies Used at Reference Centres to Monitor National Security


To raise the national biological safety system’s level of sensitivity in Russia, a system of reference centres has been created, whose primary mission is to ensure the country’s biological safety. There are more than 70 such centres, many of which are based on the leading scientific organizations of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. Reference centres are the leading scientific and technological link of the national biosafety system, where they analyse epidemiological risks and pathogens of infectious and parasitic diseases, introduce achievements of synthetic biology, the latest technologies for studying pathogens, and the state of natural foci, while also conducting in-depth molecular genetic research. Yet, microorganisms inevitably evolve, which leads to the emergence of new infections and the ensuing race for biotechnology advancement increases the risk that pathogens will be used illegally, including those created artificially. What latest technologies are being used by reference centres to ensure biological safety in Russia? What digital, genetic, and biotechnologies will be used in reference centres in the near future for effective monitoring? How do reference centres respond to biosecurity threats domestically and internationally? How does the system of reference centres influence the development of the entire healthcare system?

Session topics :
Technological Sovereignty in Biological Safety

Moderator:
Vladimir Kutyrev — Director, Russian Anti-Plague Scientific Research Institute "Microbe"

Panellists:
Andrey Biryukov — Head of the Reference Center for Infectious and Viral Oncopathology, Academician B.V. Petrovsky Russian Scientific Center of Surgery
Vadim Govorun — Director, Research Institute of System Biology and Medicine (RISBM)
Roman Kozlov — Chief Freelance Specialist of the Ministry of Health of the Russian Federation for Clinical Microbiology and Antimicrobial Resistance; President, Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC); Rector, Smolensk State Medical University
Dmitry Kutaev — Deputy Head for Research, 48 Central Scientific Research Institute of the Ministry of Defense of the Russian Federation
Lyudmila Mikhaleva — Director, Avtsyn Research Institute of Human Morphology of the Petrovsky National Research Centre of Surgery
Alexey Noskov — Director, Rostov-on-Don Plague Control Researsh Institute
Sergey Tsarev — Head of the Reference Center for Verification of Information about the Biological Threat of the Spread of Immunodeficiency States of the Human Body and Related Infections, National Research Center – Institute of Immunology Federal Medical-Biological Agency of Russia


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 3
14:00–15:30
Why Aren’t Science and Business Better Friends and Why Do Scientists Trust only the State?


Government funding of science in Russia has increased significantly over the past 20 years. This is a positive trend that has allowed the country to make significant upgrades to research infrastructure and set the standard in a number of scientific areas. The current situation in the world has Russia following the lead of BRICS members states, which are developing dynamically and possess the resources necessary to lead the way technologically. As countries like China use business to drive scientific achievement, the correlation between investment in science involving the business community and growth in GDP is clear. How can we move past just supporting science to start investing in it? Are state efforts enough to ensure technological sovereignty? How can we engage business in the development of future technologies? What kind of relationship should exist between business and scientific institutions to ensure collaboration is mutually beneficial? What success stories already exist and what can we do to ensure best practices spread?

Session topics :
An Ecosystem for Future Technologies

Moderator:
Valeria Kasamara — Director, Association of Organizers of Student Olympiads "I am a Professional"

Panellists:
Igor Drozdov — Chairman of the Board, Skolkovo Foundation
Dmitry Zauers — Deputy Chairman of the Management Board, Gazprombank
Aydar Ishmukhametov — Director General, Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences
Vladislav Ovchinsky — Head of the Department of Investment and Industrial Policy of Moscow
Natalya Popova — First Deputy General Director, Innopraktika
Ekaterina Solntseva — Chief Digital Officer, State Atomic Energy Corporation ROSATOM
Vyacheslav Shulenin — General Director, Moscow Center for Healthcare Innovations

Front row participants:
Maxim Ostras — Director of Strategic Development, LIFT Center; Head, QLU
Irina Khvorostyan — Partner, Head of Technology Practice, KEPT
 
Last edited:

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194
...Continues:


Programme 13.02.2024
...
World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 4
14:00–15:30

Creation of Artificial Organs and Biological Systems: Technologies of the Future

Transplantology is a special field of medicine that aims to treat patients with the most severe cases. Advancements in recent years in domestic vital organ transplantation have made it possible to transform this field into a truly accessible form of medical care for citizens of the Russian Federation. High levels of scientific research in this area, as well as a focus on achieving practical results, including the creation of artificial, bio-artificial organs, and high-tech equipment, are all very significant for strengthening Russia’s technological and biomedical sovereignty. Prospects for the development of transplantology involve the creation of compact implantable biological systems and technical devices that could become an effective alternative to human organs, as well as the development of ways to achieve active longevity in otherwise doomed patients. What makes modern transplantology the aggregate of high life-saving technologies? What trends in creating an artificial heart are the most relevant today? What modern technologies for clinical lung and heart-lung transplantation have been successfully introduced into clinical practice? What do the results achieved in the use of innovative technologies for donor organ perfusion in clinical practice indicate? What advanced technologies in transplantology will appear in the near future?

Session topics :
Regenerative Medicine: A Way to Restore Health

Moderator:
Yousef Khesuani — Co-founder, Managing Partner, 3D Bioprinting Solutions

Panellists:
Sergey Gotye — Director, Academician V.I. Shumakov National Medical Research Center for Transplantology and Artificial Organs of the Ministry of Health of the Russian Federation; Chief Freelance Specialist Transplantologist of the Ministry of Health of the Russian Federation
Maria Loginova — Head of the Laboratory of Applied Immunogenetics, Kirov Scientific Research Institute of Hematology and Blood Transfusion of the Federal Medical and Biological Agency
Elena Parovichnikova — General Director, National Medical Research Center for Hematology of the Ministry of Health of the Russian Federation; Chief Freelance Specialist Hematologist of the Ministry of Health of the Russian Federation
Oleg Rummo — Director, Minsk Scientific and Practical Center for Surgery and Transplantology and Hematology
Timur Khalilulin — Professor of the Department of Transplantology and Artificial Organs, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Front row participants:
Ilya Bozo — Director General, Gistograft; Head of the Division of Maxillofacial and Reconstructive Plastic Surgery, Petrovsky National Research Centre of Surgery
Marina Minina — Head of the Moscow Coordination Center for Organ Donation, S.P. Botkin City Clinical Hospital of the Moscow City Health Department
Vladislav Parfenov — Head of the Scientific Projects Implementation Group, Science and Innovations


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 5
14:00–15:30

Public Meeting of the Council for the Implementation of the Federal Scientific and Technical Program for the Development of Genetic Technologies for 2019–2030

Genetic technologies are a priority for Russia’s Scientific and Technological Development Strategy. Presidential Decree No. 680 dated 28 November 2018 on the Federal Scientific and Technical Programme for the Development of Genetic Technologies for 2019–2030 was introduced to better coordinate among the Russian genetic scientists working on state tasks for the development of genetic technologies in the country. The aim of the programme is to provide an effective approach to the problems of accelerating the development of genome editing and other genetic technologies, laying the necessary scientific and technological groundwork, improving measures in place to prevent biological emergencies, and ensuring national security. The programme has brought together a wide range of participants and support measures and provided for the creation of essential infrastructure while strengthening human resources and developing a network of scientific laboratories, world-class genetic research centres, and core facilities. Genetic technologies have been classified as cross-cutting, and the head of state has resolved to engage qualified customers, industrial partners, and the technological partner Rosneft. Up for consideration during the meeting will be five years of programme work, important achievements already reached, and priorities for what lies ahead.

Session topics :
Genetic Technologies: Part of the Medicine of the Future

Moderator:
Tatyana Golikova — Deputy Prime Minister of the Russian Federation

Panellists:
Mikhail Kovalchuk — President, National Research Centre "Kurchatov Institute"
Dmitry Morozov — Founder, Chairman of the Board of Directors, BIOCAD
Anna Popova — Head of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing – Chief State Sanitary Physician of the Russian Federation
Valery Falkov — Minister of Science and Higher Education of the Russian Federation
Andrey Fursenko — Aide to the President of the Russian Federation
Andrey Shishkin — Vice-President for Localization, Innovation and Energy, Rosneft


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 6
14:00–15:30

Technologies for the Non-Viral Delivery of Nucleic Acids:
Gene Therapy of the Future


The development of genetic technologies has created the possibility to correct gene defects that can lead to hereditary diseases and also made it possible to create a wide array of potential therapies for the standard treatment of cancer. The main tool for the delivery of genetic material to cells is currently viral vectors. However, this technology is fraught with many disadvantages and limitations. The immunogenicity of viral vectors can cause various side effects during their introduction and, furthermore, may never be used again. Capacity restrictions of the viral genome prevent it from delivering many therapeutic genes with long nucleotide sequences. Bearing this in mind, it is extremely relevant to develop zero-risk systems for the delivery of nucleic acids, including genetic editing tools, in order to somehow circumvent these restrictions. Technologies that can ensure the effective delivery of genes with long nucleotide sequences, including genome editing systems, will expand the areas where genetic therapy is used and will significantly reduce the cost of such therapy, making genetic therapy drugs more accessible to patients in Russia. What are the latest achievements in genetic therapy as we look to the future? What influence will new technologies have on the spectrum of application and accessibility of genetic therapy? What possibilities do modern technologies possess for delivering virus-free genes? What new areas of therapeutic application of genome editing tools currently exist?

Session topics :
Genetic Technologies: Part of the Medicine of the Future

Moderator:
Roman Ivanov — Director of the Scientific Center for Translational Medicine, Vice-Rector for Scientific and Technological Development, Sirius University of Science and Technology

Panellists:
Irina Alekseenko — Head of the Gene Immunoncotherapy Group, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences
Oleg Batishchev — Deputy Director for Scientific Work, A.N. Frumkin Institute of Physical Chemistry and Electrochemistry of the Russian Academy of Sciences
Vladimir Gushchin — Head, Laboratory of Mechanisms for the Population Variability of Pathogenic Microorganisms, Honorary Academician N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation
Alexander Karabelsky — Head of Gene Therapy Direction, Sirius University of Science and Technology
Dmitry Kostyushev — Head of the Laboratory of Genetic Technologies in the Development of Medicines, I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation
Musa Khaitov — Director, National Research Center – Institute of Immunology Federal Medical-Biological Agency of Russia


World Trade Center Moscow, entrance No. 4, 1st floor, conference hall 1. ROSATOM
16:00–17:30

Innovative Oncology

One of the key problems of modern medicine is the prevention and early detection of cancer. Scientists are attaching special importance to the creation of breakthrough technologies and the expansion of interdisciplinary interaction with their scientific colleagues – biologists, chemists, bioinformaticians, physicists, and mathematicians. Specifically, this refers to the introduction of artificial intelligence technologies into screening systems, the design and development of the latest approaches toward molecular genetic diagnostics, as well as the development and production of domestic models of heavy equipment and radiopharmaceuticals. Scientists are especially focused on personalized approaches towards curing cancer. Biotechnological developments are underway in the field of oncology. This includes cell therapy, mRNA vaccine therapy, therapy with oncolytic viral strains, as well as developments in gene editing and gene therapy. What innovative technological solutions and biotechnologies are the most effective for the treatment of malignant neoplasms? What prospects for the use of biotechnological drugs exist today? What are the key challenges facing the scientific and medical community when improving methods for the treatment of oncological diseases?

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

Moderator:
Sergey Ivanov — Director, A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Center for Radiology of the Ministry of Health of the Russian Federation; Chief Freelance Oncologist of the Central Federal District of the Ministry of Health of the Russian Federation

Panellists:
Irina Baldueva — Head of the Scientific Department of Oncoimmunology, Leading Researcher, N.N. Petrov National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation
Aleksandr Gintsburg — Director, Honorary Academician N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation
Dmitry Gorin — Full Professor, Center for Photonic Science and Engineering, Skolkovo Institute of Science and Technology (SkolTech)
Aydar Ishmukhametov — Director General, Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences
Vasily Lazarev — Deputy General Director for Research, Head of the Genetic Engineering Laboratory, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency
Alexander Petrovskiy — Deputy Director for Educational Activities, N.N. Blokhin National Medical Research Center of Oncology оf the Ministry of Health of the Russian Federation


World Trade Center Moscow, entrance No. 4, 1st floor, conference hall No. 2. Gazprombank
16:00–17:30
Biotechnologies for the Diagnosis and Treatment of Autoimmune Diseases


Autoimmune diseases are a significant challenge for medical science. Due to the fact that these diseases cause premature disability and an unfavourable life prognosis for patients (economic losses are comparable to those incurred when fighting cancer), they carry great social significance. In last decade, there has been a tendency towards an increase in the frequency of autoimmune pathologies, at a time when existing methods for treating such diseases are not able to deal with the root causes of autoimmune destruction, and are instead only focused on eliminating the consequences. Recently, Russian scientists staged a coup in the study and treatment of autoimmune diseases – the development in Russia of a unique, fundamentally new approach in pharmacotherapy of autoimmune pathologies that can become a platform for future treatments of a wide range of diseases from this group, in particular type I diabetes, which mainly manifests in children. How are innovative discoveries in autoimmunology changing the face of today’s medicine and how far has medical science advanced in the study of autoimmune diseases? Are there prerequisites for individualizing the treatment of AIDs as part of the concept of personalized medicine? What are the prospects for the further integration of innovative solutions in treating autoimmune diseases and in hands-on healthcare?

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

In partnership with R-pharm

Moderator:
Aleksandr Lila — Director, V.A. Nasonova Research Institute of Rheumatology; Chief Freelance Specialist Rheumatologist of the Ministry of Health of the Russian Federation

Panellists:
Natalia Mokrysheva — Director, Head of the Department of Personalized and Translational Medicine, National Medical Research Center of Endocrinology, Ministry of Health of the Russian Federation; Corresponding Member of the Russian Academy of Sciences
Evgeny Nasonov — Academic Director, V.A. Nasonova Research Institute of Rheumatology
Mikhail Samsonov — Chief Medical Officer, R Pharm
Ekaterina Troshina — Deputy Director – Director of the Institute of Clinical Endocrinology, National Medical Research Center for Endocrinology of the Ministry of Health of the Russian Federation
Dmitry Chudakov — Acting Director, Research Institute of Translational Medicine, N.I. Pirogov Russian National Research Medical University
Pavel Yakovlev — Director of Development, BIOCAD


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 3
16:00–17:30

The Interdisciplinary Nature of Future Technologies: Synergy

It is becoming clearer that vital technological breakthroughs will occur where different fields of knowledge meet. Biotechnology, artificial intelligence, quantum technologies, and new materials are just some of the many complementary disciplines that exist. Interdisciplinary research leads to emergent properties and transforms the technological landscape. What new areas of research might emerge? How do different technologies uncover solutions in other areas? What can we do to stimulate research where scientific disciplines intersect? What technologies will define future technological progress?

Session topics :
An Ecosystem for Future Technologies

Moderator:
Dmitry Chermoshentsev — Senior Researcher, Russian Quantum Center

Panellists:
Oleg Zhuravlev — General Director, Wormhols Implementation
Leonid Koldunov — Lecturer, Department of General Physics, Moscow Institute of Physics and Technology (National Research University)
Alexander Korsunsky — Professor, Skoltech Center for Systems Engineering
Igor Nabiev — Director of the Nano-photon scientific center, National Research Nuclear University "MEPhI"
Alexey Osadchy — Leading Research Fellow, AIRI Institute of Artificial Intelligence; Director, Centre for Bioelectric Interfaces, Institute for Cognitive Neuroscience, National Research University Higher School of Economics
Ilya Semerikov — Researcher at the Laboratory "Optics of Complex Quantum Systems", Lebedev Physical Institute of the Russian Academy of Sciences
Alexander Fertman — Director of Science and Education Department, Skolkovo Foundation


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 4
16:00–17:30

Healthcare Management Technologies amidst Digital Transformation

This new technological structure found in healthcare, brought on by modern breakthrough technologies such as blockchain, artificial intelligence, the Internet of things, metaverses, big data, and cloud computing, has forced the industry to undergo a complete digital transformation. Not only is the image of medicine and the way people interact with it changing, but the processes for managing it are also undergoing big changes. In particular, the emergence of generative artificial intelligence creates new conditions for fundamental changes in process management at all levels – from individual medical organizations up to the federal level. How are approaches to healthcare management changing at the federal and regional levels and in medical organizations? What management changes in functional healthcare units and medical organizations have been most successful? How will digital technologies bring us closer to achieving our national healthcare goals in the near future? What potential opportunities and significant contradictions await us in the digital transformation of Russia’s state healthcare system?

Session topics :
Digitalization and AI Technologies

Moderator:
Vladimir Zelensky — First Deputy Minister of Health of the Russian Federation

Panellists:
Mikhail Bakhtin — Assistant Director for Medical Information Technology, Nikiforov’s All-Russian Center for Emergency and Radiation Medicine of the Emergencies Ministry of Russia
Olga Kobyakova — Director, Federal Research Institute for Health Organization and Informatics of the Ministry of Health of the Russian Federation
Alexander Kravchenko — Minister of Health of the Kaliningrad Region
Alexey Khripun — Moscow Government Minister; Head, Moscow Healthcare Department


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 6
16:00–17:30

Gene Therapy: Past, Present, Future

Gene therapy is one of the most promising areas of the molecular medicine of the future. Gene therapy, which was originally developed primarily for the treatment of hereditary diseases, is now actively used to treat non-hereditary diseases. Currently, the most promising way to transfer genes during gene therapy is their inclusion in vectors that are built on the basis of retro- or adenoviruses. What are the benefits of personalized gene therapy? Which gene therapy approaches for treating hereditary diseases are the most effective today? Which segment of gene therapy drugs is developing the most actively and is most promising?

Session topics :
Genetic Technologies: Part of the Medicine of the Future

Moderator:
Pavel Makarevich — Head of the Laboratory of Gene Cell Therapy, Institute of Regenerative Medicine, Lomonosov Moscow State University

Panellists:
Vladimir Bozhenko — Head of the Department of Molecular Biology and Experimental Tumor Therapy, Russian Scientific Center of Radiology
Nikolay Ishmetov — Director of Special Projects, Russian Direct Investment Fund
Marina Popova — Founder, Advanced Gene and Cell Technologies (AGCT)
Denis Rebrikov — Vice-Rector for Scientific Work, Pirogov Russian National Research Medical University


.....
Programme for 14.02.2024 ->
 
Last edited:

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194
Future Technologies Forum 2024
Programme for 14.02.2024




14.02.2024

World Trade Center Moscow, entrance No. 4, 1st floor, conference hall No. 2. Gazprombank
10:00–11:30

The Emergence of Neurotechnologies of the Future

Technological progress has led to the creation of an entire myriad of technologies that aim to treat and rehabilitate neurological patients. Today, many neuro-technologies have found applications in medicine and have begun to be successfully introduced in domestic healthcare. Thus, over the last decade mechano-therapeutic rehabilitation devices (including robotic devices) have convincingly proven their effectiveness in restoring a patient’s movement and ability to walk. Virtual reality technologies that provide partial and complete immersion in a computer-generated space have become especially popular. Neural interface technologies (brain-computer interfaces) have gained serious and large-scale development over the past decade. Which neuro-technologies are the most promising in the present and in the near future? What lies ahead for us when various neuro-technologies reach critical mass and inevitably begin to hybridize with one another? What will the neural interface of the future look like? Will we move from the correction of neuro-pathologies to the augmentation of human capabilities? Will neural interfaces connect individuals into an ‘Internet of Brains’? Will it be possible to decode and reconstruct speech, thoughts, and feelings from brain activity? Will we understand the causes of neurodegenerative diseases and learn how to treat them?

Session topics :
Neurotechnologies in Healthcare

Moderator:
Veronika Skvortsova — Head, Federal Medical-Biological Agency of the Russian Federation

Panellists:
Andrey Davidyuk — Chairman of the Board of Directors, Motorica
Alexander Kolsanov — Rector, Samara State Medical University
Marya Lagarkova — General Director, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency
Mikhail Martynov — Chief Freelance Neurologist, Ministry of Health of the Russian Federation; Professor of the Department of Neurology, Neurosurgery and Medical Genetics, N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Valery Fedorov — General Director, Russian Public Opinion Research Center
Philipp Khaitovich — Professor, Vladimir Zelman Center for Neurobiology and Neurorehabilitation, Skoltech
Evgeny Shevchenko — Deputy General Director, Federal Center for Brain and Neurotechnology of the Federal Medical-Biological Agency of the Russian Federation

Front row participants:
Pavel Musienko — Head of the Laboratory of Neuroprosthetics, St. Petersburg State University; Head of Neurobiology, Sirius University of Science and Technology
Alexey Osadchy — Leading Research Fellow, AIRI Institute of Artificial Intelligence; Director, Centre for Bioelectric Interfaces, Institute for Cognitive Neuroscience, National Research University Higher School of Economics


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 4
10:00–11:30

Artificial Intelligence and Computer Vision in Healthcare

With the accumulation of large amounts of medical data and the rapid development of analytical methods based on machine learning, logical and statistical models, AI tools can change the situation in the healthcare sector at its core. AI has the ability to personalize and take into account the characteristics of various parameters for different patient models, which allows for more accurate selection methods to diagnose and treat diseases, offer self-help tactics, and provide individual assistance. In the past few years, the use of AI in healthcare has been actively developing in Russia. In a number of regions, the models that are gradually taking hold and being used belong to one of two main groups: computer vision and medical decision support systems. Computer vision is used to assist radiologists. Instead of viewing each image, the doctor just needs to describe the changes that were uncovered by artificial intelligence. Medical decision support systems analyse a patient’s records from his/her medical history (data mining his/her electronic medical record), including the results of his tests, and inform this doctor of the most likely diagnosis.

For the third year now, Moscow clinics have been using AI models to help doctors make diagnoses, which today have an accuracy rate for determining illness of 89%. A doctor’s work can be accelerated further by using AI models that automate the completion of medical documentation utilizing voice inputs. Concurrently, patient-oriented services for pre-clinical self-examination, assessment of a patient’s condition, as well as post-clinical rehabilitation (depending on the nosology) are also being actively developed. How will the introduction of AI technologies change the role of doctors in the healthcare system? What challenges might the system face when introducing AI? What will be the new organizational models of clinics? What will the clinic of the future look like? What areas of development of AI technologies in the world are the most promising? What benefits and advantages will the state, industry, and local populations receive from the introduction of AI technologies in healthcare? What has been the experience of Moscow clinics that have incorporated computer vision models? What opportunities will open up in the future due to the development of AI models?


Session topics :
Digitalization and AI Technologies

In partnership with Sberbank

Moderator:
Sergey Zhdanov — Managing Director, Director of the Health Industry Center, Sberbank

Panellists:
Dmitry Dylov — Director of the Department of Applied Medical Research, AIRI – Artificial Intelligence Research Institute; Associate Professor, Center for Artificial Intelligence Technologies, Skolkovo Institute of Science and Technology (Skoltech)
Vasily Ignatiev — General Director, R-Pharm
Kirill Kaem — Senior Vice-President for Innovations, Skolkovo Foundation
Pavel Pugachev — Deputy Minister of Health of the Russian Federation
Ilya Tyrov — Deputy Head, Moscow City Health Department
Alexey Fedorov — "Quantum Information Technologies" Scientific Group Head, Russian Quantum Center; Director, Institute of Physics and Quantum Engineering, MISIS University of Science and Technology
Evgeny Shlyakhto — General Director, Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation; Chief Supernumerary Specialist Cardiologist of the Ministry of Health of the Russian Federation


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 5
10:00–11:30

Artificial Intelligence: Saving Lives in Critical Conditions

AI has multiple and varied applications in the care of critically ill patients. It also has enormous potential for delivering emergency care and improving patient care outcomes. Methods and algorithms found in artificial intelligence and machine learning are already being used in real clinical practice. Today, these methods are being developed and applied in predominantly diagnostic areas, which use programmes that analyse data from patient records in order to recognize and identify patterns in them. In the nearest future, artificial intelligence has all the prerequisites to be actively utilized to predict a patient’s deteriorating condition and whether the disease is progressing. Likewise, AI can monitor changes in pathological processes, carry out continual pain assessment of patients in intensive care units, as well as provide prompt assistance to doctors in making complex clinical decisions. In addition, by 2030, we should expect AI to be an integral part of treatment algorithms, not only within medical decision support systems, but also in surgery, anaesthesiology, and resuscitation. What are the key principles for creating AI systems, and why are they needed? What are the potential applications of artificial intelligence in critical care? What are the most promising areas for the practical application of AI systems in the medicine of the future? What challenges does AI need to overcome today before it becomes a routine part of clinical practice? How can artificial intelligence revolutionize the care of critically ill patients and dramatically improve the efficiency of healthcare systems in the near future?

Session topics :
Digitalization and AI Technologies

Moderator:
Boris Axelrod — Chairman of the Board, Moscow Scientific Society of Anesthesiologists and Resuscitators; Head of the Department of Anesthesiology and Reanimation, Russian National Research Center of Surgery named after B.V. Petrovsky

Panellists:
Sergey Bagnenko — Chief Freelance Specialist in Emergency Medical Services of the Ministry of Health of the Russian Federation; Rector, Pavlov First St. Petersburg State Medical University of the Ministry of Health of the Russian Federation
Artem Kuzovlev — Deputy Director – Head, V.A. Negovsky Scientific Research Institute of General Reanimatology; Vice President, Federation of Anaesthesiologists and Reanimatologists (FAR)
Irina Pakhomova — Head of the Development of Information Systems in Anesthesiology and Resuscitation Group, Information Technology Center, Academician B.V. Petrovsky Russian Scientific Centre of Surgery
Sergey Petrikov — Director, N.V. Sklifosovsky Research Institute for Emergency Medicine
Denis Protsenko — Chief Freelance Specialist in Anesthesiology and Resuscitation of Moscow Healthcare Department; Director, Kommunarka Multidisciplinary Clinical Center
Valery Subbotin — Head of the Center for Anesthesiology and Resuscitation, Loginov Moscow Clinical Scientific Center; Leading Researcher, Laboratory of Clinical Pathophysiology of Critical States, V.A. Negovsky Scientific Research Institute of General Reanimatology

Boris Teplykh — Chief of the Department of Anesthesiology and Intensive Care, N.I. Pirogov National Medical and Surgical Center of the Ministry of Health of the Russian Federation

Sergey Tsarenko — Chief Freelance Specialist in Anesthesiology and Resuscitation of the Ministry of Health of the Russian Federation; Director, National Medical Research Center "Treatment and Rehabilitation Center" of the Ministry of Health of the Russian Federation


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 6
10:00–11:30

Medical Equipment and Drugs for Nuclear Medicine

Nuclear medicine is developing rapidly in Russia with medical equipment becoming more technologically advanced and more new drugs and innovative techniques for treating oncological, cardiological, neurological and other harmful diseases coming onto the scene with each passing year. Even so, more favorable conditions for developing and applying these advanced forms of nuclear medicine could be created if cooperation between the medical, research and business communities in conjunction with international cooperation between BRICS member countries among others could be harnessed to establish important infrastructure, therapeutic and diagnostic equipment, isotope products, and radiopharmaceuticals. Support from industry regulators is still required and a balance must be struck between import substitution and the exclusive market rights of services and technologies to ensure continued development of nuclear medicine and state-of-the-art equipment and drugs in Russia. What are the current trends in the development and application of medical equipment and drugs for nuclear medicine? What support measures from the government and industry regulators are needed to establish an advanced development model for nuclear medicine? What affect does cooperation between the medical, scientific, and business communities have on the quality of new diagnostic and treatment methods and the speed with which they can be introduced?

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

In partnership with the State Atomic Energy Corporation ROSATOM

Moderator:
Kirill Komarov — First Deputy General Director, Director of the Development and International Business Unit, State Atomic Energy Corporation ROSATOM

Panellists:
Alexey Ansheles — Leading Researcher, Radiologist, Academician E.I. Chazov National Medical Research Center for Cardiology of the Ministry of Health of the Russian Federation
Badma Bashankaev — Deputy of the State Duma of the Federal Assembly of the Russian Federation; Member of the State Duma Committee on Health Protection
Tigran Gevorkyan — Deputy Director for the Implementation of Federal Projects, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation
Sergey Glagolev — Deputy Minister of Health of the Russian Federation
Julia Dyakova — First Deputy Director for Science, National Research Center "Kurchatov Institute"
Andrey Stanzhevsky — Deputy Director for Research, Academician A.M. Granova Scientific Center of Radiology and Surgical Technologies of the Ministry of Health of the Russian Federation
Vladimir Chernov — Deputy Director for Science and Innovation, Tomsk National Research Medical Center of the Russian Academy of Sciences
Vasiliy Shpak — Deputy Minister of Industry and Trade of the Russian Federation



World Trade Center Moscow, entrance No. 4, 1st floor, conference hall No. 2. Gazprombank
12:00–13:30

Why Does the Brain Need to Connect to a Computer?

Brain-computer interfaces (BCIs) are devices that read signals directly from (or transmit them to) the brain, bypassing our senses. The number of areas in which BCIs can be applied is truly vast: in the early diagnosis and treatment of neurological conditions and brain diseases (including Parkinson's disease, epilepsy, depression, and hypertension); in mental health monitoring; in the restoration of lost cognitive abilities and motor functions; in the ability to transform thought and intention into speech; and in areas where objects can be controlled by the power of thought. In addition to medicine and healthcare, such technologies can also be used in smart homes. In one form or another, neural interfaces are one of the recent technological trends that cannot help but develop further. Today, humanity has already approached the dividing line between science fiction and real everyday life, and it will be very interesting to explore what advantages lie ahead for people when this line is crossed. What sets apart the current state of world technologies in the field of neural interfaces? Domestic versus foreign markets of neuro-technologies: what are their difference and what is the interest of large businesses? What are the most common applications of BCIs known today? What are the main advantages and disadvantages of BCIs today? What is preventing the widespread adoption of BCIs?

Session topics :
Digitalization and AI Technologies

In partnership with Gazprombank

Moderator:
Dmitry Zauers — Deputy Chairman of the Management Board, Gazprombank

Panellists:
Nikita Bukreev — General Director, SensoryLAB
Sergey Ivanov — Executive Director, Member of the Board of Directors, EFKO Management Company
Mikhail Lebedev — Chief Researcher, I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences
Maxim Ostras — Director of Strategic Development, LIFT Center; Head, QLU
Vasily Popkov — Head of the Scientific Group "Invasive Neural Interfaces", Institute of Artificial Intelligence, Lomonosov Moscow State University (MSU)
Alexey Khalezov — Lead Architect, Neiry


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 4
12:00–13:30

Development of Nuclear Medicine in Russia: Present and Future

Nuclear technologies in medicine are advanced methods for diagnosing and treating oncological, neurological, and cardiovascular diseases. However, for the effective use of such technology in healthcare, it is essential to create a unified legislative and regulatory framework, improve the system of state control and supervision, as well as coordinate how scientific research and technological developments are introduced into clinical practice. Only an interdisciplinary and systematic approach will ensure that key objectives for the creation of nuclear medicine centres in Russia are carried out, as well as ensure efficiency, quality, and safety when using nuclear physics technologies to provide high-tech medical care. The effective implementation of these objectives requires the development of a network of nuclear medicine infrastructure, as well as extremely vital practical international cooperation. Which trends and main focus areas of nuclear medicine are relevant today? What is the reason for the growing need in Russia and neighbouring countries for nuclear technologies in medicine? What measures are required from industry regulators to achieve an advanced model for the development of nuclear medicine?

Session topics :
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies

Moderator:
Mikhail Kovalchuk — President, National Research Centre "Kurchatov Institute"

Panellists:
Vladislav Baranov — Chairman of the Board of Directors, "My Medical Center" Group of Companies
Sergey Deev — Professor, Chief Researcher, Academicians M.M. Shemyakin and Y.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences
Kirill Komarov — First Deputy General Director, Director of the Development and International Business Unit, State Atomic Energy Corporation ROSATOM
Konstantin Kotenko — Director, Academician B.V. Petrovsky Russian Scientific Center of Surgery
Olga Krivonos — Deputy Chief of Staff of the Government of the Russian Federation

Front row participants:
Stepan Kalmykov — Vice-President, Russian Academy of Sciences
Vladimir Shevchenko — Rector, National Research Nuclear University MEPhI


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 5
12:00–13:30

Value-Based Healthcare: A New Approach to Patient Engagement

One of the key targets for modernizing Russia’s healthcare system is to become value-based orientated and, in doing so, create a functional ecosystem to support this while uniting regional, federal, and independent clinical information systems, for which patients will be assigned a central role. By ecosystem we mean the elimination of information asymmetry between the doctor and the patient, the creation of a ‘Digital Medical Profile’ for each citizen, the introduction of telemedicine and remote health monitoring using the ‘Personal Medical Assistant Platform’, the use of medical products with the function of remote data transfer and the proactive service ‘Digital Process Diaries’, and accumulating clinical recommendations and standards of medical care to identify health risks. The realization of value-based medicine will require forward-thinking implementation as its scope will increasingly extend beyond mere individual healthcare organizations, and will involve multi-stakeholder collaboration at local, national, and international levels, and will undoubtedly face resistance from healthcare professionals whose roles will be partially replaced by new technologies. What steps are needed from the medical community, business, and government to implement a new approach for interaction with patients? What challenges accompany the transition to a patient-centred healthcare system? What are the development prospects for value-based healthcare in Russia and around the world?

Session topics :
Digitalization and AI Technologies

Moderator:
Olga Kobyakova — Director, Federal Research Institute for Health Organization and Informatics of the Ministry of Health of the Russian Federation

Panellists:
Saida Gadzhieva — Deputy Head of the Moscow City Health Department
Damir Engalychev — Medical Director, Element Laboratory
Sergey Zhdanov — Managing Director, Director of the Health Industry Center, Sberbank
Vladimir Zelensky — First Deputy Minister of Health of the Russian Federation
Sergey Lezhnin — Chief Executive Officer, RT DOKTIS
Vitaliy Omelyanovskiy — General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Anna Sharipova — Managing Director for National Projects, Russian Technologies State Corporation


World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 6
12:00–13:30

The Place of Popular Science in Science: How to Attract and Promote

Information spreads – in great quantity – in the modern world as quickly as technology develops. Unfortunately, reliable, easily navigable sources of information tend to be limited to more traditional sources, and the industry lacks authoritative information hubs. Should platforms be created for related content where scientists can systematically access verified information? How should we be safeguarding new formats that can be accessed by young people? How can we share complex ideas without harming the quality of the material?

Session topics :
An Ecosystem for Future Technologies

Moderator:
Ruslan Novikov — General Director, Argumenty I Facty

Panellists:
Dmitry Komendantov — Government Relations Director, VK
Artem Krasheninnikov — Director General, Communication Agency "Pictures"
Denis Sekirinsky — Deputy Minister of Science and Higher Education of the Russian Federation
Stanislav Straupe — Head of Quantum Computing Sector, Center for Quantum Technologies, Lomonosov Moscow State University; Head of the Scientific Group of Atomic and Optical Quantum Computing, Russian Quantum Center
Andrey Timonov — Acting Director of the Communications Department, State Atomic Energy Corporation ROSATOM
Leonid Shlyakhover — President, Foundation for the Development of Scientific and Cultural Relations Challenge



World Trade Center Moscow, entrance No. 4, 2nd floor, conference hall 3
14:00–16:30
Plenary session


President of the Russian Federation
Vladimir Putin


The Forum aims to provide an open platform for dialogue between representatives of the government, business and scientists in order to develop joint steps for research and technology in areas that will shape global development and the future of mankind in the near term. Our job, Russia’s top priority, is to use the enormous potential of such innovative solutions to ensure economic growth and improve the quality of people’s lives.


 
Last edited:

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194
Digitalization and Artificial Intelligence to Be Discussed at Future Technologies Forum 2024


Biotechnology in Personalized Healthcare


Genetic technologies are part of the medicine of the future
 

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194
Roscongress Foundation

10 Feb at 15:00
There are only a few days left before the start of the second Forum of Future Technologies, the construction of premises in the WTC is in full swing. We will tell you about what awaits the participants firsthand.

Grigory Velikikh, Project Manager and Deputy CEO for Expert and Analytical Work of the Roscongress Foundation:

• About the concept

The forum is dedicated to science and its practical application in terms of advanced technological solutions. Last year, it was a block of quantum technologies. This includes biomedical, neurobiotechnology, and technologies related to the healthcare industry in general. The main goal is to promote the advanced ideas of the Russian and foreign expert community.

• About the exhibition

One of the key elements of the forum. Probably, the largest stand will be at the Ministry of Health of the Russian Federation, where the main developments of the industry will be demonstrated. At the exhibition, you will be able to communicate with developers who are ready to talk about their products.

• About the program


Almost all key areas contain amazing technological solutions. For example, developments in the field of neurobiotechnology. First of all, when it comes to the brain-computer interface. In Russia, there are deeper and better developments in this area than those promoted by foreign colleagues. The forum will show how far we are at the forefront here.

The participants will also touch upon the issues of regenerative medicine. There are amazing technological solutions that are in the process of entering the practical field. Biotechnology, artificial intelligence, etc. are on the agenda, and this is a kind of assembly that will fundamentally change the methods of management and coordination in the personalization of modern medicine.
And, of course, we will talk about genetic technologies, where our country, in partnership with foreign experts, is at the forefront of technological progress.

• BRICS

In addition to events under the auspices of BRICS, there will be a fairly wide representation of experts, scientists and businessmen from the BRICS countries.

• Interest in the forum

We see a significant increase in the number of applications. There is also increased interest from the press.


 
Last edited:

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194
In connection with the above,

let us recall how continuous and grading line this consistent plan follows:





















...Etc., in brief
 

truuuman

Newbie
Joined
Feb 8, 2024
Messages
1
Hey Lalas and thank you for your effort.

Was it you in substack "noosfera" who got banned? He was writing similar stuff and got deleted.

Substack seems to be somewhat free speech atleast more than twitter etc.

So the censorship was very interesting for such niche topic.
 

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194
Hey Lalas and thank you for your effort.

Was it you in substack "noosfera" who got banned? He was writing similar stuff and got deleted.

Substack seems to be somewhat free speech atleast more than twitter etc.

So the censorship was very interesting for such niche topic.
Thank you! :)
I'm tired, truuuman. Tomorrow I will answer you in detail, we will discuss things. Now I'm tired..
 

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194
Hey Lalas and thank you for your effort.

Was it you in substack "noosfera" who got banned? He was writing similar stuff and got deleted.

Substack seems to be somewhat free speech atleast more than twitter etc.

So the censorship was very interesting for such niche topic.
I will again postpone this response with a huge apology, thanking you again for your unprecedented inclusion, confirming something I have said but any do not believe me. I postpone it because I have to deal with "covering" this very important major forum, which presents technologies that, according to Putin, "will shape the future of the world."

I cover the forum, here, where no one will understand, and when I give them a link, again the "reliable" alt-media and commentators do not care (or anything else?...). I'm covering the forum myself because that shit Riley will either not cover it again or reflect it very vaguely, emphasizing BUSINESSMEN GREF AND SOBYANIN (!!), and add that "there's no stopping this... You don't want Ted Kaczynski's fate, do you?" garnished with his usual subtle humor because he's a funny guy.

And, Riley's shit will continue completely seamlessly in Substack, infecting the brains of more interested readers who don't get caught up in the 5D chess narrative, but who care about the truth. After that, Substack's absolutely accepted, shitty Riley, will continue to serve them the slashed, softened and balanced version of the controlled russian alt-press revelations.

And his partners in the reliable, balanced research group off-guardians will continue to publish it, share it across channels, and refer to Riley's monumental revelations as a comprehensive source of everything important to know about Russia's involvement in Great Resett.

And with Riley, there's a real war. If you are interested in more details, see Rollo: a real war, an inter-oligarchic dispute, over Medvedchuk! Look at the rest of the group: "We are not saying that they are all together, there are disputes between them, they are not together, but they are subordinate to the same program and probably fight for a championship in it." So "war" is not part of great reset (as a continuation of plandemia), but is "dispute for a championship in great reset". No matter that without the "war" there would not have been such a crazy and smooth advance of Great Reset (especially for Russia, but also for everywhere).

All of which is garnished with Riley's incredibly truncated limited and distorted report on the Russian great reset (in which report, he omits an incredible number of things, including the most fundamental to understand its depth). He misses the pillars. Things I've posted here repeatedly, and I'm continuing. The same things that both Substack and others don't allow to be show, and the ones they allow just neglect them and cite Riley's teenage shit report.

Add to that all the remaining balanced fog that said group throws at their audience.

Do you see the difference?

That's how it goes.

But they are an important group, for the Sifting.

At this stage we are at, information coverage must be strictly and finely regulated and shaped to encompass in the web of fraud (which is a tool for managing the "workflow optimization" for smooth running of great reset) the largest possible number of people at different levels, to satisfy the desires of "understanding the reality" of each mind from top to bottom, if it posible.

(Other variant: if they are not opperatives, they are idiots and the biggest gift for the nwo)

As I have said and continue to say: this is a conspiracy to chip. (You'll never hear about it from the off-guard band).

And so on :D :D :D

And now - to the forum! :eek:
 
Last edited:

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194

February 9, 2024
...
"Tucker Carlson: So when does the AI empire start do you think?

Vladimir Putin: (Laughing.) You are asking increasingly more complicated questions. To answer them, you need to be an expert in big numbers, big data and AI.

Mankind is currently facing many threats. Due to genetic research, it is now possible to create a superhuman, a specialized human being – a genetically engineered athlete, scientist, military man.

There are reports that Elon Musk has already had a chip implanted in the human brain in the USA.

Tucker Carlson: What do you think of that?

Vladimir Putin: Well, I think there’s no stopping Elon Musk, he will do as he sees fit. Nevertheless, you need to find some common ground with him, search for ways to persuade him. I think he’s a smart person, I truly believe he is. So you need to reach an agreement with him because this process needs to be formalized and subjected to certain rules.

Humanity has to consider what is going to happen due to the newest developments in genetics or in AI. One can make an approximate prediction of what will happen. Once mankind felt an existential threat coming from nuclear weapons, all nuclear nations began to come to terms with one another since they realized that negligent use of nuclear weaponry could drive humanity to extinction.

It is impossible to stop research in genetics or AI today, just as it was impossible to stop the use of gunpowder back in the day. But as soon as we realize that the threat comes from unbridled and uncontrolled development of AI, or genetics, or any other fields, the time will come to reach an international agreement on how to regulate these things."



February 13, 2024

The message reads, in part:

“Today's rapid scientific progress opens up enormous potential in areas such as biomedicine, genetics, genomics, neurotechnology and artificial intelligence. It is crucial that the unique achievements of research teams and clinicians be implemented swiftly in practice, in our hospitals and health centres.

I would like to emphasise that we will develop domestic healthcare on an advanced technological basis at all levels, from primary care to large federal centres. And the key priority here is to build a system of medical care devoted to the individual, to a specific patient. This will lead to increasingly effective prevention, diagnosis, and treatment of dangerous diseases, and thus improve the quality and duration of people’s lives. Such a complex, large-scale task requires the consolidation of efforts of the state, medical and scientific organisations, and technology companies. And, of course, we are always open to cooperation and implementation of joint projects with foreign partners.”

~~
"Putin takes part in Future Technologies Forum plenary session | English

Russian President Vladimir Putin takes part in the plenary session of the Future Technologies Forum in Moscow on Wednesday, February 14.

The second event of its kind takes place on February 13-14 in the Russian capital, and is dedicated to cutting edge science, technology and innovation."



“Modern Medical Technologies. The Challenge of Tomorrow: Getting the Jump on Time”

February 14, 2024

The Future Technologies Forum showcases domestic scientific progress, as well as the latest achievements and best practices in various areas. In 2024, the forum focused on progress in modern medicine, the development of new medications and innovative approaches to treating diseases.

The forum, which takes place at the World Trade Centre in Moscow on February 13–14, brought together researchers, physicians, and experts to discuss the main tasks in these and other areas.

Before the plenary session, the President, accompanied by Healthcare Minister Mikhail Murashko, visited a thematic exhibition organised on the forum’s sidelines, where he was told about innovative solutions in digital, genetic, bio- and neurotechnology, AI-assisted software, and projects in regenerative and nuclear medicine. Rosatom and Gazprombank are among the companies presenting their latest innovations.


* * *

President of Russia Vladimir Putin:

Good afternoon, friends,

I am happy to welcome our Russian and foreign guests – scientists, physicians, business representatives and all participants in the Future Technologies Forum. We have created this platform to discuss promising solutions that are just being born and tested now. In some cases they are even ahead of the times, but very soon they should and certainly will dramatically change people’s lives.

Advanced developments in medicine, the topic of this forum, are among such rapidly developing areas. I would like to use this platform to share with you a holistic vision for the future of the entire domestic healthcare system. We should decide which principles and approaches we will use in planning our work and which goals we will focus on. And, naturally, we should decide – of course, with your help, colleagues – how we will create and introduce the most advanced solutions into the daily work of medical institutions.

I would like to specifically mention that a nationwide programme to fight cancer we rolled out in 2019 is clearly a priority when it comes to cooperation between the medical community, science, the state, and the regions.

More than 500 outpatient cancer care centres have been created across the country over the past five years. Recently, I had the chance to learn about the state-of-the-art oncology centres in Kaliningrad and Tula. Most importantly, the local patients, especially in Kaliningrad, which is an exclave of Russia, now have access to medical help right in their own city. High standards for diagnostics, therapeutics, and rehabilitation have been set across the country.

As a result, more than half of oncology cases are now detected at an early stage, when the prognosis is most favourable. Chemotherapy use went up by 60 percent, and radiation therapy by over 25 percent. Proton therapy has been in use since 2020. I will definitely have more to say later specifically about the achievements of Russian science, the pharmaceutical industry, and nuclear medicine.

Critically important is the fact that the significant progress we have achieved so far helped us bring down cancer mortality rates. Without a doubt, we need to do more in this crucial department and to keep on working on it. At the same time, I want our colleagues in the Government and the regions to be mindful of the fact that all these measures must be properly funded.

It is equally important to boost the effectiveness of our actions in combating cardiovascular, autoimmune, and viral diseases. By the end of the decade, we must minimise the incidence of hepatitis C, as our programme launched last year was specifically designed to do.

Furthermore, in recent years, we have made efforts to substantially improve primary care, with new outpatient clinics and district hospitals built and existing ones upgraded. Paramedic centres and outpatient clinics are opening in small towns and rural areas.

Very small communities will be serviced by mobile clinics outfitted with the necessary diagnostic equipment. Telemedicine will make high-quality healthcare readily available in small towns and rural areas, as well as in remote places.


To be continued.

 
Last edited:

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194
:rolleyes:
Translation from globalist to human language: "we will push transhumanism through medical miracles" ("... like we started doing during the 'deadly covid pandemic' ")
 

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194
February 9, 2024
...
"Tucker Carlson: So when does the AI empire start do you think?

Vladimir Putin:

[...]
There are reports that Elon Musk has already had a chip implanted in the human brain in the USA.

Tucker Carlson: What do you think of that?

Vladimir Putin: Well, I think there’s no stopping Elon Musk, he will do as he sees fit. Nevertheless, you need to find some common ground with him, search for ways to persuade him. I think he’s a smart person, I truly believe he is. So you need to reach an agreement with him because this process needs to be formalized and subjected to certain rules.
...

"Feb 12 made bombshell claims on the Russia-Ukraine War and President Putin. The tech mogul shut down possibilities of Russia losing the war with Ukraine. He also asserted that Putin ‘Would be assassinated, if he backs off’...."

So "the war" continues, FOLLOW, COMMENT, what is happening, why and who is to blame, the VICTIMS, etc... Both brain chips and genetic modifications are OFFICIALLY underway. No one is against it, on the contrary - it's GOOD for the world but we need regulations...

Tucker's entire interview was about saying this:
2 hours on seeing the problem of the "WAR", the americans, Russia's Just Opposition to Ukro-Proxies (FOLLOW WAR NEWS!!) + 2 minutes for the official announcement of the future with chips and genetic modifications
;) :D


As I have constantly said, there is no war, there is an organized optimization of the working process of the world's transition to the new technological order, which includes the highly undesirable future of chips and genetic modifications.
 
Last edited:

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194

Future Technologies Forum



photo Rosscongress Photobank
"From the life of the forum"
Date and time: 14.02.2024


14.02.2024
The Future Has Come: Scientists Presented Breakthrough Medical Technologies



At the Gazprombank stand, visitors to the Forum's exhibition area can get acquainted with an interactive card index of scientific and technological areas developing at the LIFT Center for Interdisciplinary Research in the Field of Neurobiotech, as well as two products: quantum dots with molecular in vitro diagnostics and a hardware and software complex implemented by instant neurofeedback technology.

For the first time, Rosatom is showing a new generation device designed for the treatment of oncological diseases – the Torus linear accelerator, as well as the Sanginox device, which synthesizes and delivers nitric oxide from the air to the blood circuit when used for heart-lung machines. The guests of the forum were also presented with the use of quantum technologies in solving modeling problems, which is important for the development of new materials and medicines. In addition, visitors can see models of radiopharmaceuticals, medical devices – microsources based on iodine-125, ophthalmic applicators based on ruthenium-106 (Rosatom is their only manufacturer in the Russian Federation) and strontium-90 (the only manufacturer in the world), a compact rhenium-188 generator GREN-1, as well as personalized and serial medical devices made of composites.

CardioKVARK, a resident of the Skolkovo Foundation (VEB.RF Group), presents a chair with a built-in electrocardiograph for self-recording of ECG. Chairs are successfully used in the healthcare system of Moscow, the Moscow and Bryansk regions, and the Khabarovsk Territory. Chairs are installed in MFCs, clinics and hospitals. Another innovation was presented by Skolkovo resident Roboscan. This is a robotic system of ultrasound diagnostics with the possibility of remote control, which implements the separation of data collection and analysis of results, with the possibility of remote control and subsequent full automation of the examination process, using a neural network for processing ultrasound images based on the accumulated examination results.

Sberbank presents 7 innovations in the field of healthcare, including the Hospitalization Management Center for Patients with Suspected Stroke using AI, the AIDA digital doctor assistant, the GigaChat medical assistant, and others.

Moscow medicine is one of the most dynamically developing areas of the city. Moscow is creating the medicine of the future, where the focus is on the patient and his health. For the first time, the Moscow Government's stand presents innovative solutions in an interactive format that act as a driver for the development of Moscow healthcare.

The Skolkovo Institute of Science and Technology presents the world's only method of objective biochemical testing of human mental health based on lipid biomarkers in the blood. The technique makes it possible to assess the state of mental health using omics technologies and helps doctors diagnose the disease even before symptoms appear. Here you can also get acquainted with the methods of sensing prostheses and relieving phantom pain, a blockchain-based labeling system that allows you to keep an individual record of medicines until the patient takes the drug, and other innovative solutions.

The Future Technologies Forum is held as part of the Decade of Science and Technology in Russia, announced in 2022 by the Decree of the President of the Russian Federation Vladimir Putin."


Rosscongress Photobank
From the life of the forum
Date: February 13, 2024








 
Last edited:

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194

Vladimir Putin: Russia has come close to creating vaccines against cancer

"...We need to establish ourselves as leaders in key areas of medical technology development and be prepared for any challenge, including threats of outbreak of new global epidemics"

14.02.2024
Meeting of the Working Group on Legal Regulation in the Field of Genetic Technologies, including Genome Editing, and Bioethics Prevention of hereditary diseases and reproductive and genetic well-being


Maria Vorontsova [*officially unconfirmed, but established, Putin's young daughter]

Key takeaways

The field of genetic technologies is actively developing in Russia and is entering the stage of practical implementation in the regions of the country


"The analysis of our genes is becoming a routine study, so to speak — Dmitry Trofimov, Director, Institute of Reproductive Genetics, Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation

"Now we are planning the second stage, the regional one. So, it is extremely important to understand the structure of the disorders that we identify in our case in newborn children. For a little over a year, we performed genetic tests on all newborns. Mothers who signed an informed consent were tested for all genes. Whole-exome sequencing was used — Dmitry Trofimov, Director, Institute of Reproductive Genetics, Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation


Russian business is also actively involved in the development of genetic technologies

"I would like to mention the technological partner of our program for the development of genetic technologies in the Russian Federation. This is Rosneft, which, again, is developing the Biocampus project as part of the programme. This is a project related to the accumulation of a genetic database, well, human genetics. The database will be used for scientific purposes for a wide range of search for answers to scientific problems, including tasks. Tasks related to the early diagnosis of various genetic diseases. I am very glad that such projects, large complex projects under the auspices of our programme, are still appearing and developing in the country — Elena Nechaeva, Deputy Head of the Presidential Directorate for Science and Education Policy

Genetic technologies are a very broad field of activity that concerns each of us

"We have always believed that one test, one analysis will answer all our questions, but this is not the case. And today we have a circle of genetic technologies. This is neonatal screening <... > This is a prenatal diagnosis of congenital and hereditary diseases. This is the diagnosis of the embryo before implantation. This is preimplantation diagnostics, including for monogenic diseases — Igor Kogan, Director, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology

"It's really about all of us. And over time, it seems to me that this should be perceived quite naturally, because now the overwhelming majority of people with whom you talk, and not only with ordinary people... Members of our society, but also with medical professionals, believe that genetic diseases are something rare, something orphan, and it does not concern them. And when such information comes into our hands, it very often causes horror and, accordingly, great emotions — Dmitry Trofimov, Director, Institute of Reproductive Genetics, Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation


Trouble

There are a large number of unresolved ethical and legal issues associated with genetic technologies


"And indeed, from the point of view of the development of these technologies and research, we need to improve, including from a legal point of view, to improve these educational programs, to introduce the necessary legal blocks and ethical blocks in the appropriate training of specialists in this area, because staffing plays a very important role here, especially in terms of conveying relevant information, this ethics. I deliberately avoid the term that is not appropriate here in relation to diagnoses, because there are none here, and it is the delivery of information that is extremely important" — Oleg Grin, Director, Research and Education Center for Law and Bioethics in the Field of Genomic Research and the Application of Genetic Technologies, Kutafin Moscow State Law University (MSAL)

Solutions

It is necessary to find a place for the latest genetic technologies in the field of legal regulation

"The technologies that are currently covered by such a general term in the framework of preconception research and preconception diagnostics have yet to find their place in the field of legal regulation — Oleg Grin, Director, Research and Education Centre for Law and Bioethics in the Field of Genomic Research and the Application of Genetic Technologies, Kutafin Moscow State Law University (MSAL)

"And, probably, the first step, from the point of view of improving the legal field, is, of course, the search for a place for preconception research in the system of medical services. This is really important, because it will allow those citizens who really consciously approach their reproductive choice, based on this very necessary modern model, this Russian society, the concept of responsible health, to get a more understandable legal form from this activity — Oleg Grin, Director, Research and Education Center for Law and Bioethics in the Field of Genomic Research and the Application of Genetic Technologies, Moscow State Law Institute Kutafin Moscow State Law University (MSAL)


The safety and ethics of genetic technologies depend on the people involved

"Let me somewhat reduce the demonization of biologists, geneticists, and so on, and recall such a phrase as 'discoveries and technologies in themselves cannot be demonic, they cannot be bad, but their application depends on us, how we use them' — Maria Vorontsova, Member of the Presidium, Russian Association for the Promotion of Science


"From the point of view of the development of these technologies and research, we need to improve, including from a legal point of view, to improve these educational programs, to introduce the necessary legal blocks and ethical blocks in the appropriate training of specialists in this area, because, well, staffing plays a very important role here, especially in terms of conveying relevant information, this ethics. I deliberately avoid the term that is not appropriate here in relation to diagnoses, because there are none here, and it is the delivery of information that is extremely important" — Oleg Grin, Director, Research and Education Center for Law and Bioethics in the Field of Genomic Research and the Application of Genetic Technologies, Kutafin Moscow State Law University (MSAL)

"We see that new technologies, especially if they show good results, show their high efficiency in practice, they inexorably step by leaps and bounds into our lives and become part of our lives. <... > Are we ready for this? And from the point of view of ethical and moral aspects, including legal issues — Maria Vorontsova, Member of the Presidium, Russian Association for the Promotion of Science."


Deputy Prime Minister Tatyana Golikova at a public meeting of the Council for the Implementation of the Federal Scientific and Technical Program for the Development of Genetic Technologies for 2019–2030 as part of the Future Technologies Forum at the World Trade Center in Moscow.

More about Golikova:
"...Coincidentally, this former minister of Industry V. B. Hristenko - Viktor Borisovich Hristenko, a wealthy man and businessman, President of the Business Council of the Eurasian Economic Union (EAEU) - who in 2007 signed a Order on the strategic development of the Russian Electronic Industry, which said that in the period 2016-2025, beginning a rapid development in 2020, "NANOELECTRONICS WILL INTEGRATE WITH BIOLOGICAL OBJECTS", is the husband of deputy prime minister Tatiana Golikova. On January 29, 2020, Tatyana Golikova headed the operational headquarters for the prevention of the "import and spread" of "covid19 coronavirus infection" in the Russian Federation. So - leading the pressure team-including mandatory vaccination in many sectors - on Russians to inject themselves with what's in the injections. (What's in them?)..."

Roscongress Photobank, Future Technologies Forum 2024






 
Last edited:

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194
With the help of the developed nanoparticles, it is possible to treat severe diseases, create new vaccines and change the properties of viral vectors

2024-02-14

Dmitry Kostyushev, Head of the Laboratory of Genetic Technologies in the Creation of Medicines at Sechenov University of the Ministry of Health of the Russian Federation, spoke about this at the session "Technologies for Non-Viral Delivery of Nucleic Acids – Gene Therapy of the Future".

"Today, biological instruments with a more complex structure have appeared, so we have begun to actively talk about nanoparticles and nanotechnologies," said Dmitry Kostyushev.

He also noted that nanotechnology has its limitations, such as a large number of so-called biological barriers. There is a question of targeted delivery, that is, the delivery of drugs to a specific organ affected by the disease.

He also added that in addition to high efficiency, the important properties of the system are biocompatibility, safety and the ability to overcome biological barriers.

"On the basis of "natural pneumatic mail", we have created four new types of biological nanoparticles in the laboratory. Most importantly, these nanoparticles are versatile. That is, we can deliver any biomolecules for the necessary goals and tasks," said Dmitry Kostyushev.

He also stressed that the resulting particles are programmable using simple genetic and other technologies: it is possible to change the composition, size and charge of the particles.

"In the laboratory of Sechenov University of the Ministry of Health of Russia, we have already tested technologies that allow us to deliver nanoparticles to the brain, heart, liver, and several types of human tumors," said Dmitry Kostyushev."









Rosatom's Additive Manufacturing for Bone Restoration Will Help Oncologists

According to Academician of the Russian Academy of Sciences Igor Reshetov, a new product has been developed - individual personal implants

MOSCOW, February 14, 2024. Over the course of five years, Rosatom has formed an additive manufacturing facility from scratch aimed at restoring the supporting bones of the human skeleton. Director of the Professor Levshin Institute of Cluster Oncology of Sechenov University, Head of the Department of Oncology, Radiotherapy and Reconstructive Surgery of the Sklifosovsky Institute of Clinical Medicine, Doctor of Medical Sciences, Professor, Academician of the Russian Academy of Sciences Igor Reshetov told TASS about this.

"Rosatom, in cooperation with the scientific and economic centers of our country, has done a very important job: within five years, additive manufacturing has been formed from scratch, based on domestic technologies and aimed at restoring the supporting bones of the human skeleton. This work was crowned with the receipt of three registration certificates, which brought this additive production closer to implementation in medicine," the academician said. According to him, a new product has been developed - individual personal implants. In the course of the project, individual coatings were developed that improve communication with body-friendly cells, which makes it possible to accelerate the regeneration time in difficult conditions.

"Then," the scientist said, "the idea was born to 'revive' this implant. There may be different solutions. Currently, joint developments with Rosatom are underway to create biofabrication. In addition to the fact that we get a unique implant required for a particular patient, we also populate the patient's own cells into special cells in the implant and thereby neutralize the initial contact of the body with a foreign structure. That is, by populating the implant with the patient's cells, we reduce the risk of rejection at the first stage of contact."

In the future, according to the interlocutor of TASS, it became possible to use more complex technologies for the restoration of fabric structures. "This is an even more complex technology, because the cell is a delicate substance that does not tolerate the use of force, otherwise it leads to its damage and death. Therefore, the corresponding sorting takes place in magnetic fields. This method is the most sparing for isolating the cells of the desired population," Reshetov said.

The next ambitious task facing the scientists is to connect the implant to the circulatory system, which will become the basis of a construct obtained from the combination of animate and inanimate nature, which has highly personalized characteristics. There is a third component, the so-called regeneration vectors, the use of which accelerates the implant implantation, eliminates the improper evolution of cells and promotes the germination of nerves, without which the implanted tissue will never be able to replace the living one. "Rosatom is an international corporation and sets itself the appropriate tasks - not import substitution, but the creation of advanced development technologies," Igor Reshetov summed up.

The medical achievements of the nuclear industry, including equipment that makes it possible to grow new vessels, bioimplants, new possibilities of radiopharmaceuticals and quantum computing, were presented on Wednesday to Russian President Vladimir Putin during the Forum of Future Technologies.




February 14, 2024. Russian President Vladimir Putin during a tour of the exhibition before the plenary session of the Forum of Future Technologies "Modern Medical Technologies. The Challenges of Tomorrow - Ahead of Time" at the World Trade Center (WTC).
 
Last edited:

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194
13.02.2024
The Future Biosafety Triad: Genomic Surveillance, Big Data, and Mobile Technologies



Genomic surveillance, big data and mobile technologies – as part of the business program of the Future Technologies Forum 2024, experts discussed the triad of future biosafety. The session is included in the thematic track "Technological Sovereignty in the Field of Biosafety".

The session was moderated by Anna Popova, Head of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing and Chief State Sanitary Doctor of the Russian Federation. Front row participants: Vadim Govorun, Director of the Research Institute of Systems Biology and Medicine of Rospotrebnadzor, Areg Totolyan, Director of the St. Petersburg Pasteur Research Institute of Epidemiology and Microbiology of Rospotrebnadzor, Vlady, Director of the Russian Research Anti-Plague Institute "Microbe" of RospotrebnadzorMir Kutyrev, Senior Technical Advisor of the International Pathogen Surveillance Network (IPSN) of the Center for the Collection of Information on Pandemics and Epidemics of the World Health Organization Josephine Campos, Chief Researcher of the Research Institute of Systems Biology and Medicine of Rospotrebnadzor Elena Ilyina, Head of the 48th Central Research InstituteSergey Borisevich, Director of the Martsinovsky Institute of Medical Parasitology, Tropical and Vector-borne Diseases of the I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation Alexander Lukashev, Assistant to the Minister of Health of the Republic of Serbia Jelena Jankovic.

Russia is one of the leaders in ensuring biological safety and provides assistance to other states in this area, said Anna Popova, State Sanitary Doctor of the Russian Federation: "We have been talking about new technologies for epidemiological surveillance and anti-epidemic response for a long time. Technology is changing, but today gives us incredible new opportunities. What we had in the pre-pandemic period was advanced technologies, the export of which many countries were interested in. Our colleagues from Asia, Africa, South America, and Europe were happy to listen to us, hear us, and come to us for these technologies. They turned to us for technologies to prevent serious complications from the flu. We were the first on the continent and practically in the world to vaccinate up to 60% of the total population against influenza annually."

For timely forecasting and prompt response to threats to biological safety and ensuring the analysis of the sanitary and epidemiological situation in our country, a triad of technologies is successfully used: genomic surveillance, mobile technologies and big data analytics, including AI analytics and big data superintegration technologies, said Sergey Borisevich, Head of the 48th Central Research Institute of the Ministry of Defense of the Russian Federation: "Over the past 20 years The world has experienced three pandemics: SARS, coronavirus infection and monkeypox. In each of these pandemics, the efforts of scientists have been focused on diagnostics, primarily genomic epidemiological analysis, and on mobile technology. In our country, the technology for assessing the protective efficacy of medicines is well developed. The analysis of the properties of biological pathogens allows us to choose a laboratory model, without which it is impossible to quickly and quickly develop a particular drug."

Infrastructure has already been created, including mobile laboratory complexes, which make it possible to detect new pathogens and changes in the virulence of known strains of bacteria circulating in Russia and neighboring countries in near real time.

The participants of the expert discussion discussed what technologies for genomic surveillance and big data analysis for biosafety are available today and are being implemented in Russia and in the world, what mobile laboratories of the future will be like and what innovations will have an impact on their development, as well as what developments are most effective for prompt response to threats and improving the level of biosafety in Russia."


~~
Roscongress Photobank
From the life of the forum
Date: February 14, 2024






 

Lalas

Star
Joined
Nov 8, 2022
Messages
1,194
14.02.2024
...
The first of the forum blocks, dedicated to genetic technologies, opened with a session on the topic of gene therapy drugs. The subject of discussion was the use of gene therapy, its possibilities and limitations. The main issue was to overcome the fundamental problems of the sphere, which would make it possible to create personalized drugs for the treatment of people with genetic disorders.

"Post-genomic technologies are what we use now, after the decoding of the human genome, the sequence of their DNA. Genomic technologies have revolutionized the process of diagnosis. And before that, we made it possible to understand the causes and pathogenesis of hereditary diseases," said Sergey Ivanovich Kutsev, Director of the Research Center for Medical Genetics.

Another block of the forum was devoted to neurotechnologies. Experts discussed which neurotechnologies are considered the most promising, what awaits us when their improvement inevitably leads to the fact that neurotechnologies begin to hybridize with each other, and, accordingly, what the neural interface of the future will look like.

"Neuroscience is one of the fastest growing areas of science and technology. At the same time, many important issues, such as how the brain functions, what are the mechanisms for the development of neurodegenerative disorders, how consciousness and mental processes are connected to molecular biological mechanisms, remain unresolved," said Veronika Skvortsova, Head of the FMBA of Russia.

Finally, the forum's experts tried to answer the question of what the technologies of the future need to become the technologies of the present. In their opinion, the selection of priority areas of research dictates the formation of qualitatively new approaches to the expert assessment of funded projects.

"In less than a hundred years, we have increased life expectancy by several decades. Historically, this is some kind of fantastic result, and a full-fledged and active life. And this is largely due to medicine and pharma. At the same time, health problems have become weapons. Issues such as limited access to medicines, vaccines, and new medical technologies began to arise," said Andrei Fursenko, Aide to the President of the Russian Federation.

The Forum of Future Technologies continued on February 14, 2024. In addition to the blocks of the business program, the forum presented an exposition with innovative developments in the field of genetic and biotechnology, neurotechnology, as well as a program using the capabilities of artificial intelligence."


13.02.2024
Technology Against Neurodegenerative Diseases


...
"Scientists from all over the world are trying to understand the mechanisms of the emergence and course of neurodegenerative diseases, to develop means of their treatment and prevention. Today, there are already approaches that can slow down the development of such diseases, eliminate many significant symptoms, and improve the quality of life of people. There are individual treatment and patient management programs," said Daria Kryuchko, Head of the Department of Translational Medicine and Innovative Technologies of the Federal Medical and Biological Agency (FMBA of Russia).

Individual programs allow each patient to choose the optimal treatment regimen, including drug methods based on genomic analysis, neurosurgical and neurorehabilitation innovative technologies.

"Our task - specialists in the field of fundamental medicine, neurologists, neurosurgeons, psychiatrists, specialists in medical rehabilitation - is to identify such patients as early as possible, to prescribe therapy in a timely manner. Thus, to reduce morbidity, disability and mortality. If we talk about strategic objectives, this is, first of all, an increase in life expectancy, improving the quality of life of patients, including cognitive longevity," said Nikolay Shamalov, chief freelance neurologist of the Ministry of Health of the Russian Federation, in his speech.

The participants of the expert discussion "Technologies vs. Neurodegenerative Diseases" discussed the development of advanced technologies for the diagnosis and treatment of this group of diseases, talked about which method for determining the hereditary risk of developing Alzheimer's disease is the fastest and most cost-effective, what is the present and future in the treatment of neurodegenerative diseases, as well as which personalized rehabilitation programs for patients with neurodegenerative diseases have proven to be the most effective and successful.
 
Last edited:
Top